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 I 
SUMMARY 
Arterial blood gas (ABG) analysis provides essential detailed information on the blood 
gas and acid-base content of the blood in acutely ill patients. However, sampling of 
arterial blood is not without drawbacks as sampling to some extent is a technically 
challenging procedure. Furthermore, arterial puncture is painful for the patients and   
up to 59% develop subcutaneous haematoma following the procedure. Sampling of 
venous blood is a less painful alternative. However, venous blood gas (VBG) values 
do not approximate the ABG values with a clinical acceptable level of accuracy.  
The venous to arterial conversion (v-TAC) method is a software program that has been 
developed to transform VBG values to compatible ABG values. This transformation 
is based on a mathematical simulation that inverts the process of gas exchange which 
occurs in the capillaries when blood travels from arteries to veins. In 2015, this method 
was implemented into blood gas analysers in the emergency department (ED) at the 
North Denmark Regional Hospital as part of a pilot project. However, the utility of 
the method has not, so far, been evaluated in real-time conversion of blood gas values 
in a daily clinical practice setting, and moreover there is a gap is a gap of knowledge of 
the validity of the method in patients with extreme pathophysiological abnormalities. 
These areas were elucidated in three studies. 
In Study A, the validity of the v-TAC method and different sampling procedures were 
examined in a random ED patient population. We concluded that sample obtainment 
in 4.5 mL heparinised venous blood sampling tubes was safe, and samples could be 
stored up to 15 minutes if not tilted before being analysed. The strength of agreement 
was acceptable for all parameters except PO2. Extreme-to-extreme misclassification of 
PO2 was unacceptably high. 
In Study B, the utility of v-TAC and selected venous blood gas values was assessed in 
conjunction with the triage process among patients admitted consecutively to the ED. 
A large proportion of the patients were detected with abnormal blood gas values but 
only few with severe deviations from normal reference intervals (NRI). Interestingly, 
most of these patients were at high risk of being overlooked in a following physician 
panel audit regarding the need for blood gas analysis. No associations were observed 
when comparing the patients’ blood gas values with the assigned level of triage 
urgency, which on the contrary only showed a weak correlation with level of venous 
lactate.    
In Study C, the validity of the v-TAC method was assessed in critically ill patients 
admitted to the ICU. In this patient group, the method calculated blood gas values 
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with clinically acceptable or marginal levels of accuracy. The method might not 
estimate pH values with acceptable validity in critically ill patients with diabetic 
ketoacidosis.  
In summary, the v-TAC method offers a less painful alternative to obtain blood gas 
analysis by venous sampling as opposed to arterial puncture. If assessment of 
oxygenation status is imperative or the patient is critically ill, an ABG sample should 
be recommended. The v-TAC method contributes obvious benefits in patients 
requiring repeated blood gas analysis as this method may reduce the need for painful 
arterial punctures.  
  
 
 
 
 
 
 
 III 
RESUMÉ 
Arteriel blodgas (ABG) analyse giver essentiel information on oxygenerings- og syre-
baseindholdet i blodet hos akut syge patienter. Arteriepunktur, som er metoden 
hvormed ABG-prøver opsamles, er dog vanskelig at udføre for klinikeren idet arterier, 
i modsætningen til vener, ikke er synlige gennem huden. Derudover er proceduren 
smertefuld for patienterne of 59% udvikler subcutant hæmatom efterfølgende. 
Venepunktur, til opsamling af venøs blodgas (VBG), er mindre smertefuld for 
patienten, men VBG-værdier estimerer ikke ABG værdier med klinisk tilfredsstillende 
præcision.  
Venøs til arteriel konvertering (v-TAC) er et software program, som er udviklet til at 
transformere VBG værdier til estimater af ABG-værdier. Denne transformation er 
baseret på matematisk simulation og inverterer gasudvekslingsprocesses under blodets 
transport fra arterier gennem kapillærer og til venerne. I 2015 blev denne software 
implementeret i blodgasanalyseapparater i akutmodtagelsen (ED) på Regionshospital 
Nordjylland i forbindelse med et pilotprojekt. Anvendeligheden af v-TAC-metoden til 
realtid konvertering af blodgasværdier i daglig klinisk praksis er dog ikke tidligere 
blevet undersøgt, og tilmed er metoden ikke undersøgt tilstrækkeligt hos kritisk syge 
patienter med ekstreme patofysiologiske anormaliteter. Disse problematikker belyses 
gennem tre forskellige studier.  
I Studie A undersøges validiteten af v-TAC-metoden og forskelige prøvehåndterings-
metoder med inklusion af en tilfældig ED-patient population. Vi konkluderede, at 
prøveopsamling i 4.5 ml hepariniserede venøse blodprøveglas var sikkert, og 
blodprøverne kunne opbevares i 15 minutter inden analyse, hvis de ikke rystes.  
I Studie B blev v-TAC og VBG-værdier screenet for abnorme værdier hos konsekutivt 
indlagte ED-patienter, for at undersøge anvendeligheden af v-TAC-metoden til 
detektering af respiratoriske eller metaboliske sygdom, og for at undersøge 
sammenhæng mellem blodgasværdier og nødvendighed for akut behandling målt ved 
triage. En stor andel af indlagte patienter blev detekteret med abnorme blodgasværdier, 
men kun få havde alvorligt devierende værdier. Af patienterne med alvorligt devierende 
værdier ville kun en lille andel havde fået undersøgt blodgasværdier vurderet ud fra en 
post-hoc analyse udført at et panel af klinikere. Ved sammenligning af patienternes 
blodgasværdier og niveauet af triage fandtes ingen åbenbar association. Venøs laktat 
viste som den eneste blodgasparameter en meget svag korrelation med niveauet af 
triage. 
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I Studie C blev validiteten af v-TAC-metoden undersøgt hos kritisk syge patienter 
indlagt på intensiv afdeling. Hos denne patientgruppe beregnede v-TAC-metoden 
blodgasværdierne PCO2 og pH med acceptabel og marginal nøjagtighed. Metoden 
beregner måske ikke pH hos patienter med kritisk sygdom grundet diabetisk 
ketoacidose med tilfredsstillende præcision og nøjagtighed.  
I opsummering tilbyder v-TAC-metoden et mindre smertefuldt alternativ til 
blodgasanalyse. Hvis vurdering af valid oxygeneringsstatus er imperativt, eller 
patienten er kritisk syg, bør en ABG-analyse foretrækkes. v-TAC-metoden har 
åbenlyse fordele hos patienter, hvor hyppig eller rutinemæssig blodgasanalyse er 
påkrævet, idet behovet for smerteful arteriepunktur kan reduceres. 
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1. BACKGROUND 
1.1. HISTORY OF MEASURING BLOOD GAS VALUES 
Examining gas content in blood began as early as 1670 when Magnus, Hooke, and 
Boyle obtained gas from blood by means of a vacuum pump (1). Boyle and Hooke 
further observed that providing a constant flow of air through the trachea would keep 
dogs with multiple pleural punctures alive even without movement of the lungs (2). In 
1754, Black first described ‘fixed air’ which was generated by heating or acidifying 
chalk, and later he proved that the same gas was present in exhaled air (3). Until this 
point, no one realised that during respiration something was removed from air and 
something else added.  
Priestley discovered ‘dephlogisticated air’ by heating mercuric oxide and observed a 
much brighter flame than in plain air, but it was Lavoisier who recognised Priestley’s 
gas as oxygen (O2) in 1777 after observing phosphorous and sulphur gain weight when 
heated (2,4). Lavoisier realised that oxygen combines with fuel when burning takes 
place and theorised that Black’s ‘fixed air’ must consist of carbon and oxygen (carbon 
dioxide, CO2). In collaboration with mathematician Laplace, Lavoisier concluded that 
the principle of heat generation when coal burned in a fire was the same process taking 
place in the body (2).  
In the following one and a half centuries, haemoglobin, pH-electrodes, and acidic and 
alkaline salts were discovered in blood (2), but it was not until Henderson formulated 
the laws of mass action for weak acids and their salts in 1907 that the buffer solutions 
in blood were better understood (5). Hasselbalch adapted Henderson’s laws to the 
logarithmic form in 1917 creating the Henderson-Hasselbalch equation, which is 
applied nowadays in clinical acid-base analysis (5,6): 
pH	=	pK	+	log
[HCO3- ]
[CO2]
 
Equation 1. The Henderson-Hasselbalch equation. 
 
The clinical use of blood gas analysis originated from the epidemic of poliomyelitis in 
the early 1950s, which showed unprecedented mortality rates in Denmark. Up to 90% 
in of the patients with bulbar paralysis died, and chief physician and epidemiologist 
Lassen from Blegdams Hospital in Copenhagen, Denmark, sought help from Ibsen, a 
free-lance anaesthetist at Copenhagen’s University Hospital, Denmark (7). Ibsen 
proposed using hand-supplied positive pressure to assist respiration in patients with 
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CO2 retention due to respiratory failure (8). The treatment was implemented, and 
mortality rates decreased to 25% (2). Throughout the epidemic, approximately 1,500 
medical and dental students participated in 165,000 hours of life-preserving breathing 
assistance in polio patients by squeezing rubber bags (9).  
Total CO2 blood content was measured using Van Slyke’s method as ventilation 
guidance, but shortly after the epidemic ended, Radiometer A/S, Denmark, began 
manufacturing analysers that measured pH and partial pressure of CO2 (PCO2). 
Furthermore, Astrup’s equilibration method was implemented in these instruments so 
that bicarbonate (HCO3-) and base excess could be calculated (2,10), and soon after, 
blood gas and acid-base values were used in the assessment of patients with a variety 
of respiratory and metabolic conditions (2). 
1.2. ARTERIAL BLOOD GAS ANALYSIS TODAY 
Arterial blood gas (ABG) analysis provides essential detailed information on 
oxygenation, circulation, ventilation, and acid-base status in acutely ill patients (11–13). 
The parameters generally measured by modern blood gas analysers are pH, PCO2, 
partial pressure of O2 (PO2), concentration of haemoglobin (Hb), dyshaemoglobin 
(carboxyhaemoglobin, COHb, and methaemoglobin, MetHb), lactate, glucose, and 
electrolytes (sodium, potassium, and chloride), while HCO3 and base excess are 
calculated from measured values (14–17).  
In intensive care units (ICU) many patients have arterial catheters (AC) for direct blood 
pressure measuring, which simplifies arterial sample collection (18). However, in other 
hospital wards, arterial blood is collected by puncturing an artery, typically the radial, 
brachial or femoral artery, although arterial blood can be obtained from any artery 
carrying oxygenated blood (17). 
1.2.1. DISADVANTAGES OF ABG 
In general, serious adverse events occurring in conjunction with ABG sampling are 
rare. The rate of adverse events such as air or clotted-blood embolism, arterial 
occlusion, or introduction of contagion in relation to arterial puncture is not available 
in the literature (18–20), but the incidence rate of artery pseudoaneurysm following 
arterial puncture has been estimated to 0.05% (21–24). However, as ABG sampling is 
a commonly ordered test (25) less severe drawbacks should be considered. 
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Figure 1. Subcutaneous haematoma. Developed after repeated arterial puncture in woman 
with COPD. Used with permission by patient. 
Less severe adverse events such as haematoma (Figure 1) after radial artery puncture 
occur in up to 59% of the patients (26,27). Pain due to the procedure is also commonly 
present. In a study by Giner et al. (28) patients reported mean (±standard deviation, 
SD) pain ratings of 3.5 (1.89) on an 11-point analogue scale (zero indicating no pain 
and 10 indicating the worst possible pain). Matheson et al. (29) found a mean rating of 
6.2 (0.4) by the patients using the same pain scale 
In a questionnaire-based follow-up study, Turner et al. (30) evaluated recall of patients’ 
collective experience of their ICU stay and found that ABG sampling was rated by 
48% of the patients as the most unpleasant experience during admission followed by 
tracheal suction in 44% of the patients. Some pain is diminished if local anaesthesia is 
infiltrated before ABG sample collection (29,31). However, ABG sampling with 
anaesthesia is still as painful as venous blood gas (VBG) sampling without the use of 
local anaesthesia (28). Moreover, ABG sampling may well in some cases be a 
challenging procedure for the clinicians to perform compared to VBG sampling 
(25,32,33). McKeever et al. (34) demonstrated that clinicians conducted arterial 
puncture successfully in 69% of the patients on the first attempt, while venous 
puncture was successfully performed in 90% on the first attempt.  
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1.3. VENOUS BLOOD GAS 
VBG has been suggested as an alternative to ABG to avoid the disadvantages 
associated with the arterial puncture described in Section 1.2.1. above. However, VBG 
pH has been found to agree reasonably well with ABG pH by systematic reviews, 
whereas the arteriovenous agreement of PO2 and PCO2 do not (35–38). Multiple 
studies have examined the arteriovenous agreement of pH, PCO2 and lactate values 
since 2014. Thus, the meta-analysis calls for an update. 
1.3.1. SEARCH STRATEGY 
PubMed Medline was searched for eligible studies comparing ABG and VBG pH, 
PCO2 and PO2, and lactate. Lactate was included as the prognostic properties of this 
parameter has been found useful in multiple studies (13,39–41). The complete search 
strategy is shown in Appendix 1.  
1.3.1.1. FLOW-CHART OF THE SEARCH 
Studies published in the last 10 years examining the agreement between ABG and VBG 
values were included. This time frame was applied as systematic reviews have described 
earlier studies. The flowchart of the search is shown in Figure 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Flow-chart of the study inclusion process for meta-analysis. 
414 records identified with PubMed 
Medline search string (Appendix 1) 
379 records excluded on basis of title or 
abstract 
 
35 records eligible for evaluation 
23 records excluded:  
- 14 records did not compare peripheral 
ABG and VBG. 
- 1 record included only children.  
- 2 records were a cross sectional reviews 
and did not compare paired ABG and VBG.  
- 5 records were already located. 
- 1 record assessed ABG and VBG PCO2 
difference only during resuscitation. 
 12 studies included in meta-analysis 
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1.3.2. META-ANALYSIS  
Twelve more recent studies were identified reporting arteriovenous agreement of 
either pH, PCO2 or lactate. None of those studies reported arteriovenous PO2 
agreement. Thus, PO2 agreement is not included in the meta-analysis. Bland and 
Altman analysis (42) was used for assessing agreement in all included studies. The 
difference between ABG and VBG values were presented as mean bias and variation 
of the difference as the 95% limits of agreement (95% LOA) defined as mean bias 
±1.96SD.  
Most of the studies presented summary data; hence an overall Bland and Altman 
analysis was not possible. Therefore, for pooling data, the arteriovenous mean 
difference and 95% CI of the difference were processed in forest plots made in the 
software program Review Manager (version 5.3.5, The Nordic Cochrane Centre) (43).  
The standard error (SE) used to compute 95% CI was calculated from the interval of 
95% LOA divided by 2 and 1.96 and again divided by the square root of the number 
of participants. The meta-analysis is based on the systematic review by Bloom et al. 
(36) as the most recently published. In the following forest plots studies reporting 
arteriovenous agreement between the respective parameters is referred to in the 
paraphrased in each forest plot figure.   
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1.3.2.1. ARTERIOVENOUS PH DIFFERENCE 
Twenty studies reported an arteriovenous difference of pH, and 13 of those were 
described by Bloom et al. (36). Figure 3 shows forest plots of all 20 studies.  
A random-effects model was applied as Higgins I2-test showed high heterogeneity 
between studies (62). Of the 20 studies, 16 (80%) included patients from an emergency 
department (ED) setting, 3 (15%) included ICU patients and 1 (5%) included patients 
admitted both to the ED and to a pulmonary medicine department.  
Pooled data available from 2461 patients in the included studies showed a mean 
difference [95% CI] between ABG and VBG pH of 0.03 [0.03 to 0.04].  
1.3.2.2. ARTERIOVENOUS PCO2 DIFFERENCE 
Twelve of 17 studies reporting arteriovenous PCO2 difference were described by 
Bloom et al. (36). A forest plot of included studies is shown in Figure 4. PCO2 values 
reported in millimetres of mercury (mmHg) in some of the studies were converted to 
kilopascals (kPa) to ensure consistency between all studies referred to in this thesis.  
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Figure 3. Pooled mean difference and 95% CI of ABG-VBG pH. 
Studies presented by dimmed text are described by Bloom et al. (36). 
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Figure 4. Pooled mean difference and 95% CI of ABG-VBG PCO2. Studies presented by 
dimmed text are described by Bloom et al. (36). Units are kPa. 
There was high heterogeneity between reported results in the 17 studies. Fifteen 
included ED patients and two included ICU patients. Data from a total of 2143 
patients showed a mean difference [95% CI] of -0.66 [-0.89 to 0.31] kPa. 
1.3.2.3. ARTERIOVENOUS LACTATE DIFFERENCE 
Nine studies assessed arteriovenous lactate agreement. Bloom et al. (36) described 
three of the included studies. Forest plots are shown in Figure 5 with the difference in 
lactate reported in millimoles per litre (mmol/L). 
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Figure 5. Pooled mean difference and 95% CI of ABG-VBG lactate. Studies presented by 
dimmed text are described by Bloom et al. (36). Units are mmol/L. 
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There was high heterogeneity between the studies and pooled mean difference [95% 
CI] between ABG and VBG lactate from 959 patients was -0.38 mmol/L [-0.48 to -
0.28]. Of the nine studies, six included ED patients and three included ICU patients.  
1.3.2.4. RECAPITULATION OF THE META-ANALYSIS 
Gennis et al. (44) reported the highest mean difference [95% CI] between ABG and 
VBG pH of 0.060 [0.051 to 0.069], while Malatesha et al. (53) reported the lowest of 
0.015 [0.003 to 0.027]. The widest 95% LOA from a Bland and Altman analysis of 
agreement was reported by Malatesha et al. (53) with a mean bias (95% LOA) of 0.015 
(-0.1 to 0.13). This study was included in the meta-analysis by Bloom et al. (36). All 
recently-included studies have reported narrower 95% LOA between ABG and VBG 
pH. Thus, the additional knowledge did not support a change of Bloom et al.’s 
conclusion that ABG and VBG pH do agree within reasonable levels.  
In the comparison of ABG and VBG PCO2, the lowest mean difference [95% CI] was 
reported by Shirani et al. (55) of -0.27 [-0.39 to -0.15] kPa in normotensive patients, 
and the highest by McCanny et al. (56) of -1.15 [-1.38 to -0.91] kPa. The widest 95% 
LOA was reported by Shirani et al. (55) with a mean bias (95% LOA) on -0.36 (-3.45 
to 2.73) kPa in hypotensive patients. The intervals of the 95% LOA varied greatly 
between studies from 1.76 kPa as reported by Ak et al. (51) to the 6.18 kPa as reported 
by Shirani et al. (55). Bloom et al. (36) concluded that VBG PCO2 compared to ABG 
PCO2 varied too substantially to be relied upon in clinical practice. This conclusion 
should be maintained.  
 
In the comparison of ABG and VBG lactate, the lowest mean difference [95% CI] was 
reported by Hynes et al. (60) of -0.16 [-0.34 to 0.02] mmol/L. The highest mean 
difference [95% CI] between ABG and VBG lactate was reported by Theerawit et al. 
(72) of -0.66 [-1.04 to -0.28] mmol/L. This study included patients admitted to the 
ICU with sepsis or septic shock. The widest 95% LOA was reported by Theerawit et 
al. (72) with a mean bias (95% LOA) of -0.66 (-3.66 to 2.33) mmol/L.  The intervals 
of the 95% LOA varied greatly between studies with Datta et al. (71) reporting the 
lowest of 1.6 mmol/L. Bloom et al. (36) stated that VBG lactate could be used as a 
proxy for ABG lactate. While this seems to be true in normotensive non-ICU patients, 
the recent study results indicate that clinicians should use caution when applying VBG 
lactate in hypotensive patients with sepsis or septic shock (71–73). 
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1.4. PROBLEM STATEMENT 
The literature suggests that blood gas values are useful in the process of identifying 
critically ill patients who could benefit from early targeted medical intervention. 
Hucker et al. (74) showed that a combination of blood gas values (pH, PCO2, etc.) 
and measurements of vital signs could help to identify patients admitted to the ED at 
risk of severe disease deterioration and also to predict mortality with an area under the 
receiver operating curve (AUC) of 0.84. Furthermore, in a systematic review, Vincent 
et al. (75) concluded that kinetics of lactate constituted a robust prognostic clinical 
parameter in the evaluation of the critically ill patients in general, and not only septic 
patients. In another systematic review, Zhou et al. (76) showed that arterial lactate and 
the number of organ failures predicted mortality in ICU patients with acute-on-chronic 
liver failure. Similarly, Barfod et al. (77) concluded that venous lactate was 
independently associated with in-hospital mortality of critically ill patients admitted to 
the ED.  
The systematic review by Bloom et al. (36) and the updated meta-analysis have shown 
that VBG values obtained from the less painful venous puncture deliver reliable pH 
values which could replace ABG pH in most situations if slightly different normal 
reference intervals (NRI) are applied (78). In contrast, VBG PCO2 may vary 
considerably and to an extent that this parameter is difficult to rely upon as a 
replacement for ABG PCO2. 
While blood gas values may be useful as a screening tool in the ED setting, arterial 
puncture is unfit as a widespread routine practice due to pain for the patients and its 
challenging sampling procedure as discussed in Section 1.2.1.  
It is not only in the ED setting that pain related to arterial puncture poses a problem. 
Hospitalised patients with the need of blood gas assessment on a close routine 
monitoring basis (e.g., patients with acute exacerbation in chronic obstructive 
pulmonary disease) may also benefit from a less painful venous blood gas sampling 
procedure. Local anaesthetics have been shown to reduce the discomfort for the 
patients (28,31), but unfortunately, local infiltration analgesia is seldom applied before 
arterial puncture in the daily clinical practice (79). 
Different procedures have been proposed to correct the inaccuracy of VBG values for 
better estimation of ABG values. Several models based on linear regression has been 
proposed to form equations for estimation of ABG values from VBG values (80–82). 
Boulain et al. (83) calculated ABG values from central venous blood gas values and 
clinical measurements using a logistic regression model. Both studies showed that 
calculating ABG from VBG was a feasible analytical step.  
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In 2006, Rees et al. (84) introduced venous to arterial conversion (v-TAC, Obimedical, 
Denmark), which is a method for calculating blood gas (caBG) values by converting 
VBG values in combination with peripheral saturation measured by pulse oximetry 
measurements to ABG values. This method is based on a mathematical simulation that 
inverts the process of gas exchange that occurs in the capillaries when blood travels 
from arteries to veins.   
In 2015, the v-TAC software was incorporated into blood gas analysers in the ED at 
the North Denmark Regional Hospital as a pilot project. The validity of the method, 
however, had never been evaluated in real-time conversion of blood gas values in a 
daily clinical practice setting before.  
Only limited knowledge was available regarding the robustness of the method under 
different VBG sample handling conditions in daily clinical practice, and it was 
unknown which patient groups would benefit from implementation of this blood gas 
analysis method.  
The v-TAC method is based on the principle that the peripheral limb is well perfused, 
and the amount of acid added from the tissue to the blood is small. However, this may 
not be true in the critically ill patients, and there is a grave gap in the literature on the 
validity of the method in critically ill patients with severe respiratory and metabolic 
acidosis or alkalosis. 
1.4.1. OBJECTIVES 
Toftegaard (85) previously published a PhD thesis on the mathematical and technical 
aspects of the v-TAC method and functions using laboratory-acceptable performance 
criteria.  
As the next step, this PhD thesis has elaborated on the clinical perspectives of the v-
TAC method. One of the main objectives has been to assess the validity and utility of 
the v-TAC calculated values in the ED setting with a particular interest in blood gas 
values as a supportive screening tool in the triage process. Another main objective has 
been to evaluate the validity of the v-TAC method in the critically ill patient group 
with various respiratory or metabolic disturbances in order to fill the gap of knowledge 
on the robustness of the method under extreme pathophysiological circumstances. 
These objectives have been addressed in three separate studies.   
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1.4.1.1. AIMS OF THE STUDIES 
1. In Study A, the aim was to test the validity of the v-TAC method and different 
sample handling procedures in a random haemodynamically stable ED 
patient population.  
2. In Study B, the aim was to assess the utility of v-TAC calculated and selected 
venous blood gas values as a screening and triage aid tool to determine the 
usefulness of routine blood gas analysis in a consecutively admitted ED 
patient population.   
3. In Study C, the aim was to test the validity of the v-TAC method in a critically 
ill ICU patient population.  
 
Valid results from blood gas analysis are essential for correct assessment and treatment 
of patients; hence this thesis will remain critical towards the v-TAC method as a trusted 
tool in the clinical practice.  
In studies A and C, the alternative hypothesis that a clinically significant difference 
between ABG and caBG values was expected was tested. The null hypothesis, that no 
difference was expected, is a secondary point of navigation.  
Study B is an observational explorative study; thus, formulating a hypothesis is futile. 
However, it was anticipated that caBG and selected venous blood gas values are not 
useful as a screening and triage aid tool.  
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2. METHODS  
2.1. THE VENOUS TO ARTERIAL CONVERSION METHOD 
The v-TAC method was applied in the conversion of venous blood gas values to 
arterial blood gas values in all three studies; thus, a general description of the principles 
of the method will be given in this section. The method calculates arterial values of 
pH, PCO2 PO2 and oxygen saturation in the blood (SO2) from VBG values obtained 
from a peripheral vein and the peripheral oxygen saturation measured by pulse 
oximetry (SpO2). Figure 6 shows the five steps of conversion of blood gas values 
referred to as arterialisation. 
 
 
Figure 6. The principles of the v-TAC method. Reproduced with permission from the 
publisher (84). 
 
Each step will be summarised in the following based on descriptions by Rees et al. 
(84). 
1. Step A, the venous values of pH, PCO2, PO2, Hb, COHb, MetHb, and SO2 
are measured in a VBG sample by a blood gas analyser, and peripheral blood 
oxygen saturation is measured by pulse oximetry. Parameters with subscripts 
a, v, and p symbolise arterial, venous, and plasma values, respectively.  
2. Step B, from the measured values the total venous CO2 content (tCO2,v), the 
total venous O2 content (tO2,v), the concentration of venous base excess 
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(BEv) (NB in this context BE is defined as the concentration of strong acid 
necessary to titrate blood plasma to pH 7.4), the concentration of 2,3-
diphosphoglycerate (DPG), and the concentration of total venous plasma 
non-bicarbonate buffer base (tNBBp,v) is calculated. DPG is formed in red 
blood cells from glycolytic metabolism and binds to haemoglobin, which 
increases the energy required for oxygen to bind to haemoglobin. Thus, DPG 
moderates the affinity of haemoglobin for oxygen (86). The tNBBp is 
calculated if measurements of strong ions, Na+, K+, and Cl-, are available. 
Otherwise, a fixed value of tNBBp = 23.5 milliequivalent per litre (mEq/L) 
is applied.  
3. Step C, the variables tCO2,v, tO2,v, Hbv, BEv, DPGv, and tNBBp,v  are used to 
calculate arterial values. However, four assumptions are necessary to perform 
the calculation. The assumptions are:  
 
o DPGv = DPGa.  
o Hbv = Hba. 
o tNBBp,v = tNBBp,a.  
o The respiratory quotient (RQ) is 0.82 (87).  
 
Then, the tO2,a is calculated by adding a concentration of O2 (∆O2) to tO2,v 
and tCO2,a is calculated by subtracting the RQ multiplied with ∆O2. 
4. Step D, then the arterialised values of tCO2,a, tO2,a, Hba, tNBBp,a and DPGa 
are used to calculate arterialised values of pHa, PCO2,a, PO2,a and SO2,a.  
5. Step E, the difference between the arterialised oxygen saturation SO2,a and 
SpO2 measured by peripheral pulse oximetry is used to calculate an error that 
used to vary the value of ∆O2 and steps C to E are repeated which gives an 
error of zero. Using the adjusted value of ∆O2 the concentration of tCO2,a is 
re-calculated. Consequently, the venous values of pH, PCO2, PO2, and SO2 
are converted to arterialised values.  
2.2. STUDY A 
2.2.1. DESIGN AND SETTING 
In this study the validity of the v-TAC method and different sample handling processes 
were tested in clinical practice in an ED patient population. This study was divided 
into a methodological pre-study in which the sampling procedures and sample 
containers were evaluated, and a clinical validation study in which appropriate sample 
handling procedures and agreement between ABG and v-TAC caBG values were 
assessed.  
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The study was conducted in the ED at the North Denmark Regional Hospital. This 
hospital offers 24-hour acute care facilities with medical, surgical, and ICU services for 
250,000 citizens in the North Denmark Region. All patients are handled in the ED 
facilities, except patients with major trauma, ST-segment elevation myocardial 
infarction, or certain subspecialised injuries such as eye or urological trauma. The ED 
has approximately 15,000 patient contacts annually and is staffed by physicians in 
postgraduate clinical training and senior medical professionals.  
2.2.2. STUDY PARTICIPANTS  
Hemodynamically stable ED adult patients requiring both ABG for respiratory or 
metabolic assessment and routine venous blood analysis for any purpose were included 
in the study. Thirty subjects were planned to be included, 10 patients in the 
methodological pre-study and 20 patients in the validation study. 
2.2.3. SAMPLE COLLECTION AND HANDLING 
In the methodological pre-study, paired VBG samples were collected in 4.5 mL 
heparinised venous blood sample tubes and 2.0 mL heparinised SafePICO blood gas 
syringes (Radiometer, Denmark). The samples were obtained as close to 
simultaneously as possible using a three-way stopcock attached to the standard venous 
blood sampling kit (Figure 7).  
 
Figure 7. Blood gas sampling kit in the methodological pre-study in Study A. The three-way 
stopcock was attached to the standard sampling kit for uniform and rapid sampling. 
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VBG sampling in syringes was found to be inconvenient in our hospital setting due to 
the impracticality of requiring the three-way stopcock for sampling. If the stopcock 
was neglected and samples were to be collected in syringes directly from the standard 
venous blood sampling kit, an unacceptable risk of accidental needle injury arose. This 
problem is further discussed in Section 4.2. Therefore, VBG samples were obtained in 
the 4.5 mL tubes in the validation study (Figure 8).  
 
Figure 8. VBG sampling in the validation study. 
Three VBG samples and one ABG sample were collected from each patient in the 
validation study. The attending physician performed the arterial puncture and VBG 
sample obtainment, while the attending phlebotomist collected the VBG samples. The 
three VBG samples were treated differently; the first was held steady and analysed 
within five minutes of sample collection, the second was tilted in five minutes and 
analysed after seven minutes, and the third was held steady and analysed 15 minutes 
after sample collection. ABG samples were treated as the first VBG sample. All blood 
gas samples were analysed using the same ABL800 FLEX blood gas analyser 
(Radiometer, Denmark). The VBG values were converted to caBG values using the v-
TAC software incorporated into the ABL800 FLEX analyser. Information on patient 
age, cause of admission, and comorbidities were extracted from the patient admission 
files. In the following, the caBG values from the first VBG sample handling method 
is referred to as caBG1, the second as caBG2, and the third caBG3.   
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2.2.4. DEFINING THE CLINICALLY ACCEPTABLE DIFFERENCE 
Limited evidence is available regarding what difference between ABG and caBG values 
is acceptable in clinical practice. In a questionnaire-based survey, Rang et al. (48) asked 
45 certified ED physicians to report how different ABG and VBG values of pH, PCO2, 
and HCO3- could be before they would feel uncomfortable to rely solely on the VBG 
samples in clinical practice. The physicians would accept a mean difference [95% CI] 
of pH on ±0.05 [0.04 to 0.06] and PCO2 on ±0.88 [0.74 to 1.01] kPa. Rang et al. did 
not examine which maximum difference was allowed for PO2.  
For studies A and B, the predetermined 
clinically acceptable thresholds (CATs), 
defined as the maximum clinically 
acceptable deviation of caBG values 
from ABG values, is fixed to ±0.05 for 
pH and ±0.88 for both PCO2 and PO2 
(Table 1) 
2.2.5. SAMPLE SIZE  
The required sample size for the validation study in Study A was calculated based on 
ABG and caBG agreement results reported by Tygesen et al. (88). This study was 
selected because the patient admitted to the ED was included. The predetermined 
CATs were inserted in MedCalc (version 18.6, MedCalc Software bvba), and the 
calculated minimum required paired samples were 14 using alpha level 0.05 and 80% 
power.  
2.2.6. STATISTICAL ANALYSIS 
Agreement between ABG and caBG values was assessed using Bland and Altman 
statistics (42). The mean difference between ABG and caBG values were plotted 
against the average of the values in Bland and Altman plots (89). After calculating the 
mean bias and 95% LOA the LOAs were compared with the CATs as Bland and 
Altman states that two compared methods can be used interchangeably if the mean 
bias and 95% LOA are within the CATs (42). 
Strength of the agreement between ABG and caBG values was assessed by calculating 
tolerability interval ratios. The tolerability interval ratios are calculated by dividing the 
interval of the CATs by the intervals of the actual 95% LOA observed in the study as 
Parameters 
Clinically acceptable 
ABG-caBG thresholds 
pH ± 0.05 
PCO2 ± 0.88 kPa 
PO2 ± 0.88 kPa 
Table 1. Clinically acceptable thresholds. 
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recommended by Columb (90). The interval of the CATs is 0.1 for pH and 1.76 kPa 
for both PCO2 and PO2. 
The rate of misclassification of caBG values compared to paired ABG values was 
calculated as suggested by Boulain et al. (83). However, a misclassification was defined 
as a deviation of the caBG values from the ABG values that exceeded the CATs. Rate 
of one-way misclassification was defined as the proportion of caBG values that 
exceeded the CATs once, but now twice. If the caBG values deviated more than twice 
from the ABG values, this scenario was defined as extreme-to-extreme 
misclassification. Statistical analysis was conducted using Stata (version 13 SE, 
StataCorp, College Station) and R (version 1.1.383, RStudie, Inc., USA).  
2.3. STUDY B 
2.3.1. DESIGN, SETTING, AND STUDY PARTICIPANTS 
In this observational study the utility and value of v-TAC calculated and selected 
venous blood gas values were evaluated as a screening tool for detecting patients with 
respiratory or metabolic disturbances and improving triage.  
The study was conducted in the ED at the North Denmark Regional Hospital during 
three weeks in January and February 2016. The facilities of the hospital and ED are 
described in Section 2.2.1. All patients needing venous blood sampling were included 
in the study.  
2.3.2. THE DANISH EMERGENCY PROCESS TRIAGE TOOL 
The Danish Emergency Process Triage (DEPT) tool was used in the process of 
identifying a high-acuity patient with a high risk of mortality in the ED. The DEPT 
tool consists of differently coloured triage groups based on urgency: green (not urgent, 
re-evaluation within 180 minutes), yellow (less urgent, re-evaluation within 60 
minutes), orange (urgent, re-evaluation within 15 minutes), and red (resuscitation, 
continuous re-evaluation) (Figure 9). The DEPT tool has a blue triage group for 
patients with minor injuries and complaints; however, a patient allocated to this triage 
group was not included in the study as venous blood sampling was rarely indicated.  
The DEPT tool is based mainly on clinical measurements of SpO2, respiratory- and 
heart rate, temperature, and Glasgow coma score (GCS), but also allows for a one-
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level change of DEPT score based on specific symptoms of the patient (e.g., severe 
pain) (91). 
  
Figure 9. The Danish Emergency Process Triage. Figure lent from Barfod et al. (77). 
The admission procedure in the ED at the North Denmark Regional Hospital is to 
allocate patients to a triage group immediately after admission using the DEPT tool. 
Specialised ED nurses conducted the obtainment of clinical measures of the patients 
and allocation to a DEPT group. 
2.3.3. DATA COLLECTION AND BLOOD GAS SAMPLING  
Clinical measurement, reasons for admission, and comorbidities of the patients were 
obtained from the medical file system, Clinical Suite (DXC Technology, Healthcare 
Denmark) and registered in patient records. Using the Quan-Deyo’s algorithm (92,93) 
comorbidities, obtained as ICD-9 and ICD-10 codes, were classified into the 17 
comorbidity categories.  
VBG samples were obtained by a phlebotomist in 4.5 mL heparinised tubes in 
conjunction with routine venous blood sampling upon patient admission (Figure 8 in 
Section 2.2.3). The VBG samples were analysed using an ABL800 FLEX blood gas 
analyser and converted to caBG values using the v-TAC software incorporated in the 
blood gas analyser.  
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Only caBG values of pH and PCO2 were extracted for analysis as PO2 values in 
patients with SpO2 above 96% are incorrectly calculated (88,94). As venous lactate and 
base excess are essential in the assessment of the acid-base status of the patients these 
values were also extracted for analysis (12,13,95,96). The caBG and VBG lactate and 
base excess values were extracted from Labka II (DXC Technology, Healthcare 
Denmark).  
In a post hoc analysis, a panel consisting of four physicians reviewed the patient 
records and categorised reasons for admission into the following groups based mainly 
on the affected body system:  
1. Central nervous system (CNS).  
2. Respiratory.  
3. Circulatory. 
4. Gastrointestinal.  
5. Urogenital.  
6. Endocrine.  
7. Poisoning (e.g., drugs, medicament, or biological substances).  
8. Others (e.g., observational or causa socialis admissions).  
Furthermore, the panel of physicians was asked to determine the need for blood gas 
assessment based on the patient records but not the caBG and VBG lactate and base 
excess values.  
2.3.4. INDICATIONS FOR BLOOD GAS ANALYSIS 
The panel of physicians was requested to follow national and international guidelines 
on indications for blood gas analysis. As no guidelines describe indications for 
obtainment of caBG values, the guidelines on ABG was the reference. According to 
the American Association for Respiratory Care, the guidelines on indications for ABG 
are as follows (14). 
o The need for evaluation of patients’ ventilatory (PCO2), oxygenation (PO2 
and COHb) and acid-base status; the oxygen-carrying capacity (PO2, Hb, 
COHb; and MetHb) and intrapulmonary shunt (97).  
o The need for monitoring severity and progression of documented 
respiratory, circulatory, or metabolic disease processes (14,19,98,99).  
o The need to quantify response to therapeutic intervention (e.g., oxygen 
therapy or mechanical ventilation) (19,100).  
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o The need for evaluation of gold-directed therapy in patients with sepsis, septic 
shock, and after major surgery (19,101). 
Additional high fraction of central venous/arterial PCO2 can indicate inadequate 
perfusion in patients with severe haemorrhagic shock, poor cardiac output, or during 
cardiopulmonary resuscitation or major surgery (102,103). 
No provisions were instituted to make sure the panel of physicians followed these 
guidelines in the post hoc assessment.  
2.3.5. STATISTICAL ANALYSIS 
The variance of caBG and VBG lactate and base excess between DEPT groups were 
assessed using an ANOVA (parametric) or Kruskal-Wallis (non-parametric) test. If a 
statistically significant difference between DEPT group was observed, the Spearman’s 
rank-order correlation or Pearson product-moment correlation was used to test the 
correlation between caBG or VBG lactate and base excess values and the DEPT group. 
P-values below 0.05 were considered statistically significant.  
The sensitivity and specificity of the 
panel of physician’s decision on the need 
for blood gas analysis were calculated by 
analysing patients with caBG and VBG 
lactate and base excess values outside of 
the normal reference interval (NRI).  
The NRI applied in this study is based on 
Klæstrup et al.’s findings (104), and 
Radiometer’s Acute Testing Handbook 
prepared by Seeger et al. (78). The NRIs 
are presented in Table 2. The patients 
detected with caBG and VBG lactate and 
base excess outside of NRI were analysed in a subgroup analysis to explore whether 
patients with certain characteristics or conditions were at risk of being overlooked 
regarding the need for blood gas analysis.  
Unsupervised machine learning was used to simulate a clinical assessment of the 
patients’ blood gas values in order to detect severe deviations of caBG pH and PCO2 
and VBG lactate and base excess values. The detection of these patients was attempted 
by using hierarchical clustering with single linkage and Euclidean distance. The height 
Parameters  Reference intervals 
pH, arterial 
   Both genders 
 
7.35 to 7.45 
PCO2, arterial 
   Female 
   Male 
 
4.26 to 5.66 kPa 
4.66 to 6.38 kPa 
Lactate, venous 
   Both genders 
 
< 2 mmol/L 
Base excess, plasma 
   Female 
   Male  
 
-2.3 to 2.7 mmol/L 
-3.2 to 1.8 mmol/L 
Table 2. Normal reference intervals (78,104). 
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of the dendrograms of combined caBG and VBG values of each patients was cut off 
using visual assessment to identify clusters of patients with the outermost presentation 
of combined caBG and VBG lactate and base excess values.  
2.3.5.1. HIERACHICAL CLUSTERING 
Hierarchical clustering is a type of unsupervised machine learning used to arrange data 
in trees of clusters (105). As opposed to the more well-known K-means algorithm, 
hierarchical clustering does not rely on a fixed number of clusters, and the user is, 
therefore, able to have some influence on the division of clusters (106). Single linkage 
is the simplest agglomerative hierarchical clustering approach in which each data point 
is allocated in its own cluster, and the clusters are merged iteratively until all clusters 
belong in one cluster based on the Euclidean distance from one cluster to the other 
(107,108). The arrangement of the clusters is plotted as dendrograms in which the 
height scale is an arbitrary measure of the distance between the clusters (106,109), and 
the actual distance between the clusters are presented as the edges in the dendrograms 
(109). The division of clusters relies on the observer to apply cut off lines in the 
dendrograms as shown in Figure 10.  
 
 
Figure 10. Hierarchical cluster dendrogram with cut-off line. The dots in the bottom 
represent data points and clusters whereas the edges in the dendrograms represent the 
distance between the clusters. The applied cut-off line arranges data points in clusters as 
visualised by the eclipses around the data points. The figure is shown with permission from 
the publisher (109). 
 
The number of parameters included in the machine learning analysis determines the 
dimensions of each data point. In this study, each data point will have four dimensions 
as it consists of four blood gas parameters: the caBG pH and PCO2 values, and the 
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VBG lactate and base excess values. All statistical and machine learning analysis was 
conducted using R (version 1.1.383, RStudie, Inc., USA). 
2.4. STUDY C 
2.4.1. DESIGN AND SETTING 
The objective in this validation and case series study was to test the validity of the v-
TAC method in a heterogenic, critically ill, ICU patient population. The study was 
conducted in the ICU at the North Denmark Regional Hospital from December 2017 
to December 2018.  
The seven-bed ICU receives and treats critically ill patients from the ED, medical and 
surgical wards, and patients from other ICUs in the North Denmark Region. A total 
of 17,800 surgical procedures are performed at the hospital annually (97). The facilities 
of the hospital are described further in Section 2.2.1. 
2.4.2. STUDY PARTICIPANTS 
Critically ill adult patients admitted to the ICU were included in this study if acidosis 
or alkalosis was present in the initial ABG analysis of the critically ill patients (ABG 
pH <7.35 or >7.45, respectively (78,104)). Furthermore, patients were included only 
if they had arterial catheters for ABG sampling or invasive continuous blood pressure 
measurement and peripheral venous catheters (PVC) and/or central venous catheters 
(CVC). 
2.4.3. SAMPLING PROCEDURES AND DATA COLLECTION  
The sample collection process followed standard operating procedures (SOPs) 
described before study commencement. The SOPs were approved by the chief medical 
officer of the intensive care unit. Multiple paired ABG and VBG samples were 
collected from critically ill ICU patients simultaneously from arterial catheters and 
PVC and/or CVC, respectively. Sampling from both PVC and CVC was chosen as 
CVC sampling may be desirable in certain clinical situations (e.g., problematic 
identification of blood vessels or when the peripheral circulation has shut down due 
to shock).  
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All blood gas samples were collected in 2.0 mL heparinised SafePICO blood gas 
syringes from catheters and analysed using an ABL800 FLEX blood gas analyser 
located at the ICU. All samples were analysed within five minutes after sample 
obtainment. The VBG values were converted to caBG values using the commercially 
available v-TAC method. 
Clinical measures of heart- and respiratory rate, SpO2, blood pressure, temperature, 
and information on respirator settings, simplified acute physiology (SAPS) 3 score, 
type and rate of inotropic therapy, cause of admission, and a clinical assessment of 
circulatory and oxygenation status of the patients were registered on patient charts 
(Appendix 2). 
2.4.3.1. LIMITATIONS OF THE V-TAC METHOD  
Three limitations of the v-TAC method were implemented after studies A and B were 
completed but before the commencement of Study C. The limitations were as follows:  
o Arterialisation could not be performed if venous pH was below 6.8.  
o Arterialisation could not be conducted if SpO2 was below 75%.  
o Arterialised PO2 values above 10.0 kPa was reported with the label >10.0 kPa.  
2.4.4. SAMPLE SIZE  
The minimum required sample size for the comparison of ABG values and caBG 
values from peripheral venous blood was 21 pairs, and for the comparison of ABG 
values and caBG values calculated from central venous blood, the required sample size 
was 16 pairs. Sample size calculations were performed on the basis of results reported 
by Toftegaard et al. (110). The alpha level was 0.05, and the statistical power was 80%. 
Sample size calculations were conducted using predefined CATs in MedCalc as 
presented in Section 2.2.4.  
2.4.5. STATISTICAL ANALYSIS  
Similar to statistics conducted in Study A, the agreement between ABG and caBG 
values was assessed using Bland and Altman statistics (42). However, as ABG values 
were considered the gold standard and multiple samples per patient were obtained, the 
mean bias between ABG and caBG values was plotted against the ABG values in Bland 
and Altman plots as advised by Krouwer (111). The strength of agreement between 
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ABG and caBG values was evaluated by calculating tolerability interval ratios and rate 
of one-was and extreme-to-extreme misclassification was calculated as described in 
Section 2.2.6.   
In accordance with recommendations provided by Bland and Altman (112), the 
variances of differences between ABG and caBG values were analysed in individual 
patients and between patients to determine whether 1) sample pairs should be treated 
as if they were from individual subjects or 2) averages of both ABG and caBG values 
should be calculated in each patient before comparison analysis. Bland and Altman 
recommend comparing the in-patient variance of the difference of ABG and caBG 
values with the variance of the difference of ABG and caBG values between patients 
using one-way ANOVA. If there was a statistically significant difference, the 95% LOA 
was calculated for both scenarios, and the method providing the widest 95% LOA was 
chosen.  
2.5. ETHICAL CONSIDERATIONS AND DATA PROTECTION 
All studies were conducted according to the Danish ethical regulations. The Danish 
Research Ethics Committee in the North Denmark Region was notified about the 
studies. The Danish Data Protection Agency was notified and approved all studies. 
Only approved database storage solutions were used. 
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3. RESULTS 
3.1. STUDY A 
3.1.1. METHODOLOGICAL PRE-STUDY 
The 10 ED patients included in the methodological pre-study had a median (range) 
age of 76 (26-86) years, and the distribution of gender M/F was 6/4. The mean 
difference (±SD) between pH, PCO2, and PO2 values collected in 2.0 mL syringes and 
4.5 mL tubes was 0.01 (0.01), -0.02 (0.27) kPa, and 0.57 (1.1) kPa, respectively (94). 
The difference between the 4.5 mL tube and 2.0 mL syringe was not considered 
clinically important at the time, and due to the risk of needle injury using other 
methods, the 4.5 mL tube was chosen over the syringe for VBG sampling in the 
validation study.  
3.1.2. PATIENT CHARACTERISTICS  
Twenty patients requiring ABG analysis were included in the study. Table 3 shows a 
summary of demographic features of the patients. The proportion of females was 40%. 
None of the patients were haemodynamically unstable or suffered from severe 
hypoxia. 
 
 
Demographics 
n 20 Comorbidities  
   COPD 
   Heart failure 
   Essential hypertension 
   Ischemic heart disease 
   Arterial fibrillation 
   Diabetes mellitus 
   Myxoedema 
   Small cell carcinoma 
 
8 (40) 
5 (25) 
4 (20) 
2 (10) 
2 (10) 
2 (10) 
1 (5) 
1 (5) 
Age, median (range) 66 (36 to 96) 
Gender, M/F 12/8 
Cause of admission, n (%) 
   COPD exacerbation  
   Pneumonia 
   Suspected abdomen ischemia 
   Dehydration 
   Cor pulmonale 
   Diabetic ketoacidosis 
   Dysregulated diabetes mellitus 
   Bleeding haemorrhoid 
 
6 (30) 
3 (15) 
3 (15) 
3 (15) 
2 (10) 
1 (5) 
1 (5) 
1 (5) 
Table 3. Demographics of the patients in 
Study A. COPD, Chronic obstructive 
pulmonary disease. Reproduced from 
Paper A with permission from the 
publisher (94). 
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3.1.3. COMPARISON OF ABG AND CABG  
Table 4 shows ABG and caBG values and agreement calculated using Bland and 
Altman statistics. Higher mean bias and broader 95% LOA were observed in all 
parameters in the comparison with caBG2, which was calculated from tilted VBG 
samples. The tilting treatment produced an increase in PCO2 of 0.5 kPa, which caused 
a decrease in pH. A minor increase in PO2 was also observed.  
 
Parameters ABG 
Mean (±SD)  
caBG  Bland and Altman analysis 
Type Mean (±SD)  Mean bias 95% LOA 
   pH 
 
7.42 (0.05) 
 
caBG1 
caBG2 
caBG3 
7.42 (0.05)  
7.39 (0.04) 
7.42 (0.05) 
0.00 
0.03 
0.00 
-0.04 to 0.03 
-0.01 to 0.07 
-0.03 to 0.03 
   PCO2, kPa 
 
4.9 (0.6) 
 
caBG1 
caBG2 
caBG3 
5.0 (0.6) 
5.5 (0.6) 
5.0 (0.6) 
 
 
-0.01 
-0.54 
-0.01 
-0.47 to 0.38 
-1.09 to 0.02 
-0.48 to 0.46 
   PO2, kPa 10.3 (1.8) caBG1 
caBG2 
caBG3 
11.2 (NA) 
11.5 (NA) 
11.3 (NA) 
 
 
 
-0.96 
-1.25 
-1.00 
NA 
NA 
NA 
Table 4. ABG and caBG values in Study A. ABG, arterial blood gas; caBG, calculated arterial 
blood gas using v-TAC; 95% LOA, 95% limits of agreement; caBG1, VBG analysed within five 
minutes; caBG2, VBG tilted in five minutes and analysed after seven minutes; caBG3, held 
steady and analysed after 15 minutes. Standard deviations of caBG PO2 values were 
erroneously presented in Paper A; however, the mean difference between ABG and caBG PO2 
did not follow a normal distribution and should not be presented. Reproduced from Paper A 
with permission from the publisher (94). 
 
The strength of the agreement was acceptable between all comparisons of ABG and 
caBG pH and PCO2 as the tolerability interval ratio was below 1 (see Section 2.4.5). 
The difference in PO2 values did not follow a normal distribution; hence, tolerability 
interval ratios should not be calculated for this parameter although this was performed 
in Paper A.  
There was no one-way or extreme-to-extreme misclassifications of caBG1 and caBG3 
pH compared to ABG values, but the rate of one-way misclassification of caBG2 pH 
was 10%.  Similarly, there was no misclassification of caBG1 and caBG3 PCO2 values, 
but rate of caBG2 PCO2 one-way misclassification was 15%. In contrast the rate of 
one-way misclassification of caBG1, caBG2, and caBG3 PO2 was 35%, 35%, and 30%, 
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respectively. The rate of extreme-to-extreme misclassification was 25%, 25% and 25%, 
respectively.  
 
3.2. STUDY B 
3.2.1. PATIENT CHARACTERISTICS  
In the three week, 631 admissions were registered in the ED. In 520 of the admissions, 
caBG and VBG lactate and base excess values and DEPT score were obtainable. 
Eight patients were re-admitted in the inclusion period, four of whom were allocated 
to the same DEPT group (green), and the four remaining patients were allocated to a 
different group upon the second admission. A summary of the demographics of the 
included patients is shown in Table 5.  
Demographics Total 
Danish Emergency Process Triage score 
P-value Green Yellow Orange Red 
n admissions 520 204 168 131 17  
Age, median (range), year 66 (9-99) 64 (9-99) 66 (13-97) 69 (18-96) 80 (57-91) ** 
Gender, M/F 239/281 101/103 71/97 61/70 6/11 NS 
Reasons for admission, n (%) 
   Gastrointestinal 
   Respiratory 
   Circulatory 
   Central nervous system 
   Urogenital  
   Poison 
   Endocrine 
   Other 
 
164 (31) 
101 (19) 
76 (15) 
52 (10) 
29 (6) 
14 (3) 
10 (2) 
74 (14) 
 
75 (37) 
17 (8) 
32 (16) 
27 (13) 
13 (6) 
3 (2) 
10 (3) 
31 (15) 
 
70 (42) 
30 (18) 
8 (5) 
10 (6) 
13 (8) 
5 (3) 
4 (2) 
28 (16) 
 
19 (14) 
46 (35) 
30 (23) 
15 (11) 
3 (2) 
5 (4) 
0 
13 (10) 
 
0 
8 (47) 
6 (35) 
0 
0 
1 (6) 
0 
2 (12) 
 
*** 
*** 
*** 
NS 
NS 
NS 
NS 
NS 
 Panel assessment, n (%) 
   BG indicated 
   BG not indicated 
 
107 (21) 
413 (79) 
 
16 (8) 
188 (92) 
 
24 (15) 
144 (85) 
 
53 (41) 
78 (59) 
 
14 (82) 
3 (18) 
*** 
Table 5. Summarised demographics of the patients in Study B. P-values: NS, not significant; 
* <0.05; ** <0.01; *** <0.001. Reproduces from Paper B. 
A statistically significant increase in the age of the patients with triage urgency was 
observed. The proportion of patients with respiratory and circulatory reasons for 
admission were significantly larger in the orange and red DEPT groups compared to 
the green and yellow groups. In contrast, the proportion of patients with 
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gastrointestinal reasons for admission was small in the orange and red DEPT groups 
compared to the green and yellow groups.  
The most frequent Quan-Deyo’s comorbidities of the patients were chronic 
pulmonary disease (n = 164, 22%), diabetes mellitus (n = 101, 14%) and previous 
history of stroke (n=76, 14%). In all Quan-Deyo’s comorbidity categories the 
proportion of patients with chronic pulmonary disease and congestive heart failure 
showed a statistically significant increase with triage urgency.  
The proportion of patients with chronic pulmonary disease increased from 13% (n = 
27) in the green DEPT group to 47% (n = 8) in the red group, and the proportion of 
patients with congestive heart failure increased from 5% (n = 11) to 18% (n = 3).  
3.2.2. BLOOD GAS VALUES AND TRIAGE URGENCY 
Median and range of caBG and VBG lactate and base excess values are shown by 
DEPT group in Table 6. Venous lactate was the only parameter which showed a minor 
but statistically significant increase with triage urgency.  
Using Spearman’s rank order, a very weak correlation between venous lactate and 
DEPT group were detected with (rs = 0.18). The range of the blood gas values shows 
that patients with extreme values were observable in the lesser urgent green and yellow 
DEPT groups.  
Blood gas values 
Median (range) All 
Danish Emergency Process Triage score 
P-value Green Yellow Orange Red 
pH,  
caBG 
7.43 
(7.20-7.67) 
7.44 
(7.25-7.65) 
7.44 
(7.27-7.67) 
7.43 
(7.20-7.60) 
7.44 
(7.28-7.51) 
NS 
PCO2, kPa, 
caBG  
4.8  
(1.8-11.0) 
4.8 
(1.8-6.8) 
4.7 
(2.8-10.1) 
4.8  
(2.6-11.0) 
4.6 
(3.9-10.2) 
NS 
Lactate, mmol/L, 
Venous 
1.4  
(0.0-14.7) 
1.4 
(0.0-6.0) 
1.4 
(0.0-4.6) 
1.6 
(0.8-14.7) 
2.0 
(0.0-4.4) 
*** 
Base excess, mmol/L, 
Venous  
1.2 
(-18.6-11.0) 
1.2 
(-16.3-8.8) 
1.3 
(-13.2-10.7) 
0.9 
(-18.6-11.0) 
1.1 
(-6.1-9.5) 
NS 
Table 6. Median (range) of blood gas values in the DEPT groups in Study B. P-values: NS, not 
significant; * <0.05; ** <0.01; *** <0.001. Reproduced from Study B. 
Patients with one or more of the caBG or VBG values outside the NRI (see section 
2.3.5.) were detected in 413 of the 520 admissions. The distribution of the 413 
registered cases by DEPT group were as follows: 67% (n admissions = 137), 76% (n 
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admissions = 127), 76% (n admissions = 99), and 88% (n admissions = 15) in the 
green, yellow, orange, and red DEPT groups, respectively (Figure 11). Although the 
proportion increased with triage urgency, the difference did not reach statistical 
significance.  
 
Figure 11. Admissions with blood gas values outside NRI by DEPT group. The hatched 
proportion represents the patients with caBG pH and PCO2 and VBG lactate and base excess 
values outside normal reference intervals (NRI). 
 
3.2.3. PREDICTION OF ABNORMAL BLOOD GAS VALUES 
The panel of four physicians decided blood gas analysis was indicated in 21% (n 
admission = 107) of the patient admissions. Among this proportion, 75% (n 
admissions = 85) were detected with caBG and VBG values outside of NRI.  
The sensitivity of the panel’s decision was 23% and the specificity was 85% in detecting 
patients with caBG and VBG values outside NRI. The negative and positive predictive 
values for the decisions were 29% and 79%, respectively.  
The panel decided that patients with respiratory reasons for admission required blood 
gas analysis most often (61%) and patients with gastrointestinal reasons for admission 
least often (4%).  
Observing only the admissions in which the panel decided that blood gas analysis was 
not required, the risk of overlooking patients with caBG and VBG values outside NRI 
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were highest in patients with gastrointestinal reasons for admission (66%) and lowest 
in patients with respiratory reasons for admission (36%).  
Using the patient group with respiratory reasons for admission as reference the odds 
ratio for overlooking caBG pH and PCO2 and VBG lactate and base excess values 
outside NRI is shown in Table 7. 
 
Reasons for  
ED admission 
n 
admissions Odds ratio [95% CI]] P-value 
Central nervous system 52 6.8 [2.6 to 20.4] *** 
Circulatory  76 5.9 [2.5 to 15.8] *** 
Gastrointestinal  164 29.4 [10.7 to 101.8] *** 
Urogenital  29 7.3 [1.9 to 41.8] *** 
Endocrine 10 2.8 [0.5 to 18.1] NS 
Poison 14 3.2 [0.7 to 20.5] NS 
Other 74 12.5 [4.4 to 44.5] *** 
Table 7. Odds ratio for overlooking caBG and VBG values outside NRI. The risk is ordered 
by patients’ reason for admission. P-values: NS, not significant; * <0.05; ** <0.01; *** 
<0.001. Reproduced from Study B.   
The odds ratio for overlooking abnormal blood gas values in patients with 
gastrointestinal reasons for admission was statistically significantly the highest, and the 
odds ratio was more than twice the risk for a patient admitted with other reasons for 
admission.  
3.2.4. MACHINE LEARNING AND ABNORMAL BLOOD GAS VALUES 
The patients with the outmost combined caBG pH and PCO2, and VBG lactate and 
base excess values were detected using cluster dendrograms with cut off limits on the 
height scale as shown in Figure 12.  
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Figure 12. Dendrogram of combined blood gas values in the green DEPT group. 
 
Cluster dendrograms from machine learning analysis in the remaining DEPT groups 
are presented in Appendix 3. Detection of patients with outmost combined blood gas 
values in the red DEPT group was not meaningful as only 17 patients were allocated 
to this group, and it already was the highest urgency level. Fourteen patients were 
detected with outmost combined caBG and VBG values in the green, yellow, and 
orange DEPT groups. Characteristics of the patients are presented in Table 8. 
 
Patient no. DEPT group 
Reason for 
admission 
caBG and VBG values  
pH PCO2 Lactate Base excess 
 1 Green Gastrointestinal 7.65 2.0 6.0 -2.1 
 2 Green Other 7.25 2.6 0.7 -16.3 
 3 Green Other 7.32 6.8 2.9 2.0 
 4 Yellow Respiratory 7.27 10.1 1.2 8.2 
 5 Yellow Respiratory 7.40 3.8 1.4 -6.4 
 6 Yellow Gastrointestinal 7.54 4.8 4.6 9.6 
 7 Yellow Gastrointestinal 7.27 3.4 1.4 -13.2 
 8 Yellow Poison 7.27 5.5 0.9 -6.7 
 9 Orange CNS 7.20 2.6 1.4 -18.6 
 10 Orange Respiratory 7.28 11.0 1.3 11.0 
 11 Orange Respiratory 7.24 5.9 0.8 -7.0 
 12 Orange Gastrointestinal 7.21 4.0 14.7 12.4 
 13 Orange Other 7.47 6.2 4.8 9.6 
 14 Orange Other 7.29 2.7 1.1 -11.6 
Table 8. Characteristics of the patients with outmost combined blood gas values. Patients were 
detected using unsupervised machine learning. Reproduced from Paper B. 
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The median (range) of the caBG pH and PCO2 and VBG lactate and base excess were 
7.28 (7.20 to 7.65), 4.4 (2.0 to 11.0) kPa, and 1.4 (0.7 to 14.7) mmol/L and -6.6 (-18.6 
to 11.0) mmol/L, respectively. One or more severely diverging blood gas parameter 
was observed in the majority of the patients, but not in all; For example, patient no. 5 
did not appear to have severely abnormal blood gas values apart from a negative base 
excess value. 
In the subgroup consisting of 14 patients, the panel of physicians decided that blood 
gas analysis was required in four. Figure 13 shows the reasons for admission of the 14 
patients and the panel decisions on blood gas need.  
 
The panel decided that blood gas analysis was required mainly in the patients with 
respiratory reasons for admission and the one patient with symptoms from the central 
nervous system. The panel concluded that blood gas analysis was not required in all 
patients with gastrointestinal reasons for admission, poisoning or other reasons for 
admissions. 
 
Figure 13. Decision on blood gas need in patient with outmost blood gas values. 
The panel conclusion refers to the decisions on blood gas need made by the panel of 
physicians in the post hoc analysis of patient records. BG, blood gas analysis. Reproduced 
from Paper B 
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3.3. STUDY C 
3.3.1. PATIENT CHARACTERISTICS  
Fifty-eight paired samples were collected from 26 patients. Sample pairs from 28 
patients were included; however, caBG could not be calculated in two patients due to 
the limitations of the v-TAC method (1 patient with pH < 6.8 and 1 with SpO2 < 75%, 
see Section 2.4.3.1).  
Demographics ABG vs caBGPVC ABG vs caBGCVC 
n 14 16 
n sample pairs  23 39 
Age, median (range) 68 (38 to 82) 72 (18 to 83) 
Gender, M/F 10/4 9/7 
SAPS 3 score, median (range)  57 (34 to 99) 70 (49 to 99) 
Inotrope therapy 
   Norepinephrine, n (%) 
      µg/kg/min, median (range) 
   Dobutamine, n (%) 
      µg/kg/min 
 
5 (35) 
0.32 (0.03 to 1.00) 
0 
 
8 (50) 
0.41 (0.05 to 1.00) 
1 (6) 
3.0 
Reasons for admission, n (%) 
   Sepsis 
   COPDe 
   Cardiac arrest 
   Diabetic ketoacidosis 
   Hypokalaemia 
   Status asthmaticus 
   Poisoning (medicaments) 
   ARDS 
   Congestive heart failure 
   Ileus 
   Pancreatitis 
   Pneumonia 
 
4 (29) 
2 (14) 
2 (14) 
1 (7) 
1 (7) 
1 (7) 
1 (7) 
1 (7) 
1 (7) 
0 
0 
0 
 
8 (50) 
1 (6) 
1 (6) 
1 (6) 
1 (6) 
0 
0 
0 
0 
2 (13) 
1 (6) 
1 (6) 
Table 9. Demographics of the patients in Study C. SAPS 3, simplified acute physiology score 
3; COPDe, chronic obstructive pulmonary disease exacerbation; ARDS, acute respiratory 
distress syndrome. The sum of the patients appears as 30 but is 26 as caBG values were 
calculated both from VBG samples from PVC and CVC in four patients. Reproduced from 
Paper C.  
Table 9 shows a summary of demographic features of the patients in the studies. In 
four patients, VBG samples were collected both from CVC and PVC and compared 
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to the corresponding ABG sample; thus, the included number of patients appear as 30 
in the table but is, in fact, 26.  
3.3.2. COMPARISON OF ABG AND CABG  
The ABG and caBG values and mean difference (±SD) between paired is presented in 
Table 10. The limitations of the v-TAC method of only reporting PO2 values below 
10.0 kPa caused an exclusion of 14 and 18 pairs in comparison of this parameter in the 
ABG and caBGPVC and ABG and caBGCVC comparison, respectively.  
Parameters  
n paired 
samples  
ABG 
Median (range) 
caBG 
Median (range) 
Difference 
Mean (±SD) 
ABG vs caBGPVC 
   pH 
   PCO2, kPa 
   PO2, kPa 
 
 
23 
23 
9 
 
 
7.29 (6.99 to 7.50) 
5.2 (2.3 to 12.3) 
8.5 (6.2 to 11.5) 
 
 
7.31 (7.02 to 7.50) 
5.4 (1.1 to 11.8) 
8.6 (6.6 to 10.0) 
 
 
-0.02 (0.09) 
0.1 (0.4) 
-0.1 (NA) 
ABG vs caBGCVC     
   pH 
   PCO2, kPa 
   PO2, kPa 
 
 
39 
39 
11 
 
 
7.29 (6.95 to 7.66) 
5.2 (2.1 to 10.1) 
9.2 (7.5 to 14.5) 
 
 
7.30 (6.95 to 7.67) 
5.1 (2.0 to 10.0) 
9.0 (7.8 to 9.9) 
 
 
0.00 (0.02) 
0.0 (0.45) 
0.9 (NA) 
Table 10. ABG and caBG values in Study C. Reproduced from Paper C. 
3.3.2.1. BLAND AND ALTMAN ANALYSIS 
The in-patient variance of the ABG and caBGPVC (caBG values calculated from 
peripheral VBG samples) value difference was not statistically significant compared to 
the variance between patients. Therefore, averages of multiple samples of ABG and 
caBGPVC paired values were calculated in each patient.  
There was a statistically significant difference in-patient variance of the difference of 
ABG and caBGCVC (caBG values calculated from central VBG samples) pH and PO2 
values (P = .013 and P < 0.001, respectively). The calculations of mean bias and 95% 
LOA were wider when treating sample pairs as if they were from individual subjects. 
The variance of difference of ABG and caBGCVC PCO2 values was not statistically 
significant; however, mean bias and 95% LOA were identical regardless of how 
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samples were treated. To improve consistency in data presentation of the study, the 
sample pairs were treated as if they were from individual patients.  
Bland and Altman plots of agreement between ABG and caBGPVC paired values are 
shown in Figure 14 A1-3. The mean biases (95% LOA) of agreement of pH and PCO2 
was 0.01 (-0.10 to 0.09) and -0.03 (-0.73 to 0.77) kPa, respectively. The difference of 
ABG and caBGPVC PO2 did not follow a normal distribution, hence 95% LOA could 
not be calculated. The mean bias was -0.12 kPa.  
Figure 14 B1-3 shows the Bland and Altman plots of ABG and caBGCVC agreement. 
The mean biases (95% LOA) of pH and CO2 were 0.00 (-0.04 to 0.05) and 0.0 (-0.9 to 
0.9) kPa, respectively. The mean bias of PO2 was 0.9 kPa.  
An outlier was observed in the ABG and caBGPVC pH agreement. This data point 
consisted of four paired samples from one critically ill patient with diabetic 
ketoacidosis and considerable hyperventilation to compensate for the metabolic 
acidosis. In two of four pairs of this patients’ caBG pH values were calculated as being 
within normal reference intervals (pH 7.42 and 7.42, respectively), although the patient 
had severe metabolic acidosis measured by ABG (pH 7.07 and 7.16, respectively). The 
VBG from which the caBG values were calculated also showed severe acidosis (pH 
7.04 and 7.17, respectively.  Median (range) ABG pH values were 7.24 (7.07 to 7.32) 
in this patient, while caBGPVC pH median (range) was 7.37 (7.31 to 7.42). Median 
(range) of ABG PCO2 was 3.0 (2.3 to 3.6) kPa and of caBGPVC PCO2 was 2.5 (1.1 to 
3.6) kPa. All caBGPVC values of PO2 were above the limit of 10.0 kPa, in this patient.  
The difference between ABG and caBG PO2 values increased with higher measured 
values. The limitations of the v-TAC method which was introduced before Study C 
(exact values of PO2 > 10.0 kPa was not calculated) caused an exclusion of 8/14 and 
28/39 data points in the ABG and caBGPVC, and ABG and caBGCVC PO2 comparisons, 
respectively. Two data points were observed in the ABG and caBGCVC comparison of 
PO2 as the ABG values were above 10.0 kPa but the caBG values were not. 
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Figure 14. Bland and Altman plots on ABG and caBG agreement in Study C. A1-3 ABG and 
caBGPVC agreement and B1-3 ABG and caBGCVC agreement. caBGPVC, the caBG values 
calculated from peripheral VBG samples; caBGCVC, the caBG values calculated from central 
VBG samples. Reproduced from Paper C. 
In the comparison of ABG and VBG from PVC the mean biases (95% LOA) of pH, 
PCO2, and PO2 were 0.03 (-0.04 to 0.10), -0.7 (-2.6 to 1.1) kPa and 6.2 kPa, 
respectively. In the comparison of ABG and VBG from CVC the findings were 0.03 
(-0.02 to 0.08), -0.7 (-1.6 to 0.3) kPa and 6.0 kPa, respectively.  
A1                                                          B1
A2                                                          B2
A3                                                          B3
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3.3.3. STRENGTH OF AGREEMENT 
 The strength of the agreement between ABG 
and caBGPVC values was assessed by calculating 
tolerability interval ratios (TIRs). For pH and 
PCO2, the TIRs were 1.83 and 0.85, respectively, 
which is marginal, and an acceptable agreement 
(Table 11) according to Columb (90). The TIRs 
of the ABG and caBGCVC pH and PCO2 values 
in were calculated to 0.88 and 1.00, which 
equivalents acceptable and marginal strength of 
agreement. 
The strength of the agreement of ABG and VBG from PVC pH and PCO2 were 1.39 
and 2.13, respectively. Between ABG and VBG from CVC, the strength was 1.03 and 
1.12, respectively.  
3.3.4. RATE OF MISCLASSIFICATION 
The rates of one-way misclassification and extreme-to-extreme misclassification 
between ABG and caBG pH, PCO2, and PO2 values are shown in Table 12.  
Misclassification ABG vs caBGPVC ABG vs caBGCVC 
n  14 16 
n pairs 23 39 
One-way 
   pH 
   PCO2 
   PO2 
 
4.4% 
8.7% 
11.1%* 
 
7.7% 
5.1% 
0%* 
Extreme-to-extreme 
   pH 
   PCO2 
   PO2 
 
12.2% 
0% 
11.1%* 
 
0% 
0% 
18.2%* 
Table 12. One-way and extreme-to-extreme misclassification in Study C. * Pairs with caBG 
PO2 values above 10.0 kPa were excluded as the v-TAC method did not calculate exact values, 
leaving 9/23 sample pairs in the ABG and caBGPVC comparison and 11/39 in the ABG and 
caBGCVC comparison in Study B. Reproduced from Paper C 
Rates of one-way misclassification of caBGPVC pH and PCO2 to ABG values were low, 
but extreme-to-extreme misclassification of caBGPVC pH occurred in 8.7% of the 
Strength of 
agreement 
Tolerability 
interval ratio 
Acceptable < 1 
Marginal 1-2 
Unacceptable > 2 
Table 11. Interpretation of the 
tolerability interval ratio. 
Reproduced with permission from 
the publisher (90). 
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sample pairs. This misclassification was caused by deviating caBGPVC pH values in 2/4 
comparisons to ABG pH values in the patient with hyperventilation and severe 
metabolic acidosis due to diabetic ketoacidosis mentioned above in Section 3.3.2.1.  
The rate of extreme-to-extreme misclassification of caBG PO2 was marginally smaller 
if caBG values were calculated from peripheral VBG values but still high even with 
the limitations of 10.0 kPa applied.  
The rates of one-way misclassification between ABG and VBG from PVC in 
parameters pH, PCO2 and PO2 were 13.0%, 8.7% and 4.3%, respectively. Between 
ABG and VBG from CVC the rates were 20.5%, 20.5% and 0%, respectively.  
Extreme-to-extreme misclassification between ABG and VBG from PVC pH, PCO2 
and PO2 occurred in 4.3%, 13.0% and 78.3%, respectively. Between ABG and VBG 
from CVC the rates were 0%, 5.1% and 100%, respectively. 
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4. DISCUSSION  
4.1. GENERAL ASPECTS 
In this PhD thesis, the validity and utility of the v-TAC method was assessed in a 
clinical setting in three studies. The main findings in the studies are presented in the 
following. 
In a random ED population, the v-TAC method converted pH and PCO2 values to 
caBG values with high accuracy and precision compared to ABG values. VBG samples 
could safely be stored up to 15 minutes before analysing the samples and performing 
the v-TAC calculations. However, tilting samples is counter advised, at least not if the 
VBG samples are obtained in 4.5 mL tubes, as a minor increase of approximately 0.5 
kPa was observed in samples treated that way. In normoxic hemodynamically stable 
ED patients, more than half of the caBG PO2 values were misclassified (above CATs) 
when compared to ABG PO2 values.  
Systematic blood gas screening in patients admitted to the ED was performed with 
ease and without any practical or logistical obstacles. A substantial proportion of 
patients were detected with v-TAC caBG pH, PCO2, venous lactate and base excess 
values outside normal reference intervals (NRI). However, when examining the 
association between blood gas values and the DEPT triage groups, only venous lactate 
showed an association with triage urgency, although the correlation was very weak. 
Decisions on indication for blood gas analysis performed by a panel of physicians 
showed low sensitivity for detection of patients with abnormal blood gas values, but 
the specificity for detecting patients who did not need blood gas analysis was moderate 
to high. In a machine learning analysis, the patients with extreme blood gas values were 
detected, but this subgroup consisted of only 14 (3%) patients. All of them were from 
the green, yellow, and orange DEPT groups, and while most of the patients presented 
with severely abnormal blood gas values, some did not. The question remains whether 
complete routine blood gas screening in patients admitted to the ED is clinically 
justified only to identify a small proportion of patients with severely abnormal blood 
gas values at risk of being overlooked in the initial clinical assessment. Patients 
admitted for a gastrointestinal reason or reasons that did not fit into the predefined 
reasons for admissions (other reasons for admission) may, in particular, benefit from 
routine blood gas screening. 
In the critically ill patients with severe respiratory or metabolic acidosis, the v-TAC 
method validly calculated arterial PCO2 values from VBG samples collected from 
peripheral and central venous catheter sampling sites. The caBG pH values were 
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calculated with high validity, although significant bias of caBG pH was observed in 
multiple pairs from one patient. The precision of caBG pH was not superior to that of 
VBG pH. Even though the recently implemented v-TAC limitations allowed for 
reporting of only calculated PO2 values below 10.0 kPa, misclassification of 
approximately a quarter of the caBG PO2 values was observed when compared to 
ABG values. From a clinical perspective, the agreement between ABG and caBG 
values were similar regardless of whether the caBG values were calculated from 
peripheral or central VBG values. 
The methodology and findings in each study are discussed separately in the following.  
4.2. STUDY A 
In this combined methodological pre-study and validation study the aim was to test 
two samplings methods and test the effects of different VBG sample handling 
procedures on the validity of the caBG values compared to ABG values in a daily 
clinical ED practice setting.  
4.2.1. HANDLING OF VBG SAMPLES  
In the pre-study, the 4.5 mL tube was chosen over the 2.0 mL blood gas syringe as the 
preferred container for VBG samples, even though PO2 was 0.57 kPa higher in the 
tube compared to the syringe. This decision was based mainly on practical reasons as 
a three-way stopcock did not need to be connected to the standard venous blood 
sampling kit. Furthermore, if the three-way stopcock was not applied to the kit, and 
the sampling was performed with a blood gas syringe pushed directedly against the 
rubber covered needle in the blood sampling kit, the risk of accidental needle injury 
was considered significant. However, the choice of sample container may have 
contributed to the poor agreement between ABG and caBG PO2 values.  
In the validation study, the v-TAC method delivered valid caBG values of pH and 
PCO2 if samples were not tilted as the 95% LOA of the pH and PCO2 did not exceed 
the CATs. The tilting process caused a slight increase in caBG PCO2 values of 
approximately 0.5 kPa. Hence, the rate of one-way misclassification was 15%, which 
implies that VBG samples should be carefully handled and not routinely tilted for more 
than 5 minutes, at least not if collected in 4.5 mL venous blood tubes. A drop in PO2 
could have been expected as O2 is utilised in the production of CO2 (113); however, 
this was not observed. The underlying cause for this increase remains unknown. 
However, pre-analytical errors concerning air in the hose connecting the needle and 
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the tube being sucked into the 4.5 mL tube or, while there is a vacuum in the tube, 
there also might be leftover gas which may have caused the increase in PO2 or PCO2 
(114,115). 
4.2.2. ACCURACY OF PH, PCO2, AND PO2 
In the introduction of this thesis, the issue of inaccurate values of VBG PCO2 has been 
presented, and in the updated meta-analysis the 95% LOA varied greatly from 1.76 to 
6.18 kPa (51,55). The precision of mean bias but most importantly the accuracy of the 
arterial estimations of PCO2 were considerably improved by use of the v-TAC method. 
The high accuracy of caBG PO2 values has also been found in a recently published 
study by Ekström et al. (116) in which the validity of v-TAC was assessed in 46 patients 
admitted to a Swedish pulmonary medicine department. The mean bias (95% LOA) 
between ABG and caBG PO2 was -0.14 (-0.46 to 0.19) kPa. In the comparison of ABG 
and caBG pH, the mean bias (95% LOA) was 0.00 (-0.02 to 0.02). Hence, the v-TAC 
could contribute to the valid estimated of arterial PCO2.  
4.2.3. THE PROBLEM WITH CALCULATING PO2 
The validity of the v-TAC method has been assessed by Rees et al. (117) and Tygesen 
et al. (88) by including patients with COPD and patients for various reasons admitted 
to the ED, respectively. Both research teams found acceptable performance of the 
method in calculation of pH and PCO2 using laboratory-acceptable thresholds. 
However, while the mean bias of caBG PO2 was of a minor magnitude in the two 
studies, the bias increased exponentially in PO2 values higher than 8-9 kPa.  
The concern about the incorrect estimation of arterial PO2 values has been recognised 
since the introduction of the method by Rees et al. (84). In his paper, it was stated that 
the incorrect PO2 values were due to the flat shape of the oxygen dissociation curve at 
blood oxygen saturations above 96%, meaning even minor changes in oxygen 
saturation percentage would result in major changes of the calculated PO2 value. 
However, this principle also applies to the analysis of ABG PO2 (118). The selected 
sample collection tube in the study may also explain the wrongful estimation of PO2 
values as mean venous PO2 was 0.57 kPa higher in the 4.5 ml tube. 
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4.2.4. LIMITATIONS OF THE STUDY  
This study has some limitations. It was a single-centre study with a very small 
heterogenic patient population; hence, the generalisability of the results is low. 
Furthermore, no standard operating procedures were formulated to reduce risk of 
preanalytical errors and ensuring anaerobic VBG sampling in the 4.5 mL tubes. The 
validity of calculated PCO2 and PO2 may have improved if such guidelines had been 
formulated. 
4.3. STUDY B 
In this observational study the aim was to examine the utility of calculated and selected 
venous blood gas values as a screening tool to detect patients with abnormal blood gas 
values, and examine congruency with DEPT triage in patients admitted to the ED. 
4.3.1. DETECTING THE ACUTELY ILL PATIENT 
A large proportion of patients admitted to the ED were detected with blood gas values 
outside the NRI in one or more parameters (caBG pH, caBG PCO2, VBG lactate 
and/or VBG base excess). However, venous lactate only showed only a very weak 
correlation with triage urgency. This association was not unexpected as Baron et al. 
(119) and Contenti et al. (120) have found arterial and venous values of lactate to 
correlate. Moreover, lactate is useful in the evaluation of the severity of sepsis, in 
addition to prediction of resuscitation requisite and patient mortality in the ED. These 
findings were supported by Barfor et al. (41), who found venous lactate levels to be 
independently associated with mortality, and patients with measures above 4 mmol/L 
were at highest risk of mortality with an odds ratio of 19.9 [95% CI 7.3 to 55.1].  
In a cohort study by Kristensen et al. (121) including more than 12,000 patients VBG 
parameters were combined with measurements of vital signs to identify patients with 
the highest risk of mortality using a multiple logistic regression model. The AUROC 
was calculated to 0.88 [95% CI: 0.84 to 0.89], whereas the AUC was 0.63 [95% CI 59.1 
to 67.5] when using the DEPT tool only to identify patients at mortality. In contrast 
to Kristensen et al.’s findings, Iversen et al. (122) showed that a simple visual 
assessment of the patients upon admission, a so-called eye-ball triage, was not inferior 
to the DEPT tool. The simple triage was conducted by phlebotomists and medical 
students who were responsible for routine venous blood sampling. While this simple 
eye-ball approach may seem alluring, it should be emphasised that a simple clinical 
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examination did also take place during venous blood sampling (e.g., patient alertness 
feeling skin temperature). Nevertheless, the findings in this study should be considered 
in the search for the ideal triage process or tool, as a combination of blood parameters 
and clinical measures may not provide adequate assessment outcome. 
4.3.2. THE CHALLENGES OF EVALUATING INDICATIONS  
The panel of physicians in Study B did not detect patients with abnormal caBG and 
VBG values with high accuracy as the sensitivity of their decisions was low, whereas 
the specificity of the panel’s decision was high. The risk for overlooking abnormal 
caBG and VAG values was unambiguously highest in patients admitted with 
gastrointestinal reasons for admission, while it was lowest in patients with respiratory 
reasons for admission. Patients with the lowest risk of having blood gas values 
overlooked were patients with respiratory reasons for admission. In the patients 
detected with the most abnormal blood gas values, it was only those with respiratory 
reasons for admission and one patient with a central nervous system reason among 
whom the panel decided that blood gas analysis was required. 
The results suggest that evaluating indications for blood gas analysis might be a more 
challenging task for physicians than anticipated. Moreover, the panel displayed a 
predilection for judging the need for blood gas analysis in patients with respiratory 
reasons for admission; however, while respiratory symptoms may be a reason for 
analysing blood gas values, other indications are also relevant (see Section 2.3.4). 
Therefore, it is imperative to know and follow the established indications for blood 
gas analysis. 
4.3.3. LIMITATIONS OF THE STUDY  
Several limitations of this study should be considered. It was a single-centre study with 
17 patients allocated only to the red triage group and a few patients detected with 
severely abnormal blood gas values in the subgroup analysis. These circumstances 
made stratification troublesome, and the results should, therefore, be interpreted with 
caution. Electronic admission records were reviewed by the panel of physicians to 
determine the need for blood gas analysis; therefore, no proper physical examination 
was conducted. However, this procedure was necessary as physical examination of the 
patients and assessment of blood gas indication in conjunction with the triage process 
would make the triage process redundant. Furthermore, no provisions were established 
to make sure that the blood gas values were not reviewed by the physicians before 
deciding on the need for blood gas analysis. The study design and setting did not allow 
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for a follow-up on the mortality of the patients; hence, no conclusions can be drawn 
regarding the benefits of blood gas values in predicting mortality.   
4.4. STUDY C 
In this case series study, the aim was to evaluate the validity of the v-TAC method in 
a critically ill ICU patient population with various causes of admission to identify 
clinical situations in which the v-TAC method is inaccurate.   
4.4.1. VENOUS BLOOD SAMPLING SITES 
Toftegaard et al. (110) reported a clinically significant difference between the 
agreement of ABG and caBG calculated from peripheral VBG samples compared to 
agreement of ABG and caBG calculated from central VBG samples. The mean biases 
(2*SD) pH were 0.00 (0.03) in the ABG and caBGPVC comparison, and 0.01 (0.02) in 
the ABG and caBGCVC comparison. The difference in the agreement of PCO2 was -
0.04 (0.52) kPa and -0.18 (0.35) kPa in the comparison of ABG and caBGPVC and ABG 
and caBGCVC, respectively. Toftegaard et al. recommended using peripheral venous 
blood for the v-TAC conversion as blood from a well-perfused extremity is unlikely 
to have major metabolic disturbances, which may not be true for central venous blood.  
The results from Study C showed slightly broader 95% LOA in the ABG and caBG 
PCO2 agreement if the VBG samples were obtained from CVC. In the agreement of 
pH, narrower 95% LOA were observed in the ABG and caBGCVC comparison, but 
this was mainly due to the poor agreement in the patient with diabetic ketoacidosis.  
From a clinical perspective, the observed differences between caBG calculated from 
peripheral blood and central blood is small. Thus, central venous blood may be used 
for calculations of blood gas values in patients without major metabolic disturbances; 
however, the caBG results should be interpreted with caution.  
4.4.2. THE PROBLEM WITH FIXED V-TAC LIMITS  
Before the commencement of Study C, some limitations of the v-TAC method were 
formulated. A lower limit of peripheral oxygen saturation input was set to 75%, which 
is reasonable as the accuracy of many peripheral transcutaneous pulse oximetry sensors 
declines considerably in measurements below 75% (123,124). However, application of 
the fixed upper limit of PO2 on 10.0 kPa may not be just be smart.  
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The v-TAC method does take the Bohr effect into account as the DPG values are 
calculated (84,87). The Bohr effect is the principle that an increase in H+-ions (and a 
decrease in pH) lowers haemoglobin affinity for oxygen, which causes the oxygen 
dissociation curve to shift right (86,125). This principle is shown in Figure 15. 
Hamilton et al. (126)  showed that p50 (the oxygen tension when haemoglobin is 50% 
saturated with oxygen) shifted to the right by 0.7 kPa in patients with acidosis and pH 
7.24. In this present Study C pH as low as 7.0 was observed, which would result in an 
even larger right-shift. The v-TAC method may take this phenomenon into account, 
but the limits of 10.0 kPa in reported caBG PO2 does not. Instead of limits of oxygen 
tension, providing upper limits of pulse oximetry oxygen saturation may have been 
more reasonable.  
4.4.3. PITFALLS OF THE V-TAC METHOD  
The v-TAC method relies on a set of assumptions presented in Section 2.1. One of 
these is that the respiratory quotient does not vary outside the interval of 0.7 to 1.0, 
and the calculations are performed with a fixed value of 0.82 (84,87). In the critically 
ill patients, the respiratory quotient may vary substantially depending on the underlying 
 
Figure 15. The oxygen dissociation curve. 
Lent from Collins et al. (118) 
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pathophysiological mechanisms of the patients, and the method may not be valid in 
subgroups of patients with different tissue metabolism (127,128). The respiratory 
quotient was not measured in the included patients; hence, the extent of this concern 
could not be explored further.  
In the comparison of ABG and caBG pH values, a serious misclassification was 
observed in a patient with diabetic ketoacidosis. Both the ABG and VBG values 
showed severe metabolic acidosis in this patient, but the VBG values were converted 
to caBG values with normal pH. BG values showing acidosis was wrongfully converted 
to normal pH values. The reason for this serious error is unknown, but may be caused 
by the presence of acidic ketone bodies (129). 
Obimedical, the company commercialising the v-TAC method, postulates the 
following on their FAQ page regarding the use of v-TAC in patients with conditions 
with excess acids such as diabetic ketoacidosis, lactate acidosis, or salicylate poisoning. 
An excess of acid will present itself as a negative base excess in the blood. 
Our mathematical models account for changes in base excess. The v-
TACTM method assumes that the value of base excess is the same in the 
arterial and venous blood samples. Systemic, whole-body changes in acid-
base balance resulting in acid production will result in negative base excess 
in blood measured at any site. Systemic changes are therefore not a problem 
for the method.(130) 
The statement continues to explain why it should not be a problem for the method: 
For peripheral venous samples it is unlikely that there are large differences 
between arterial and venous BE values due to local acid production. This is 
particularly true if the peripheral venous site is warm and well perfused, 
which is easily identifiable by clinical inspection or by the presence of a pulse 
oximetry signal. In a warm, well-perfused extremity, the likelihood of local 
tissue anaerobic metabolism is small, and BE values should be the same in 
both arterial and venous blood at this site.(130) 
This misclassification was observed in only two ABG and caBG pairs and may not 
form a basis of a v-TAC guideline. However, an event of misclassifying extremely 
abnormal blood gas values to normal values should not be accepted in a clinical setting, 
and an ABG analysis must be applied. 
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4.4.4. LIMITATIONS OF THE STUDY  
This study has several limitations. The sample sizes were above the required sample 
sizes but small for both ABG-caBGPVC and ABG-caBGCVC comparisons. 
Furthermore, there was no statistically significant ABG and caBGPVC in-patient 
variance of the difference between methods; thus, averages of ABG and caBG values 
were calculated within each patient which lowered the total number of paired 
observations below the required sample size. In comparison of ABG and caBG PO2 
values, the majority of pairs were excluded as the caBG PO2 was above limits of the 
v-TAC method on 10.0 kPa. Selection bias may have been introduced in the study as 
all paired samples were collected as convenience samples, and sometimes the acuity of 
the patients did not allow for paired sampling as life-saving treatment was prioritised. 
Moreover, a considerable number of samples were discarded as ABG pH had reached 
normality due to treatment.  
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5. CONCLUSIONS 
In summary, we investigated the validity and utility of a method for conversion of 
venous blood gas values (v-TAC) to arterial blood gas values in different clinical 
settings.  
In a random ED population, the v-TAC method delivered adequate validity for 
calculation of arterial pH and PCO2 values. The VBG samples from which the values 
were calculated could safely be stored up to 15 minutes before sampling but should 
not be tilted routinely.  
We managed blood gas screening in admitted acute patients with practical and logistical 
ease using VBG sampling and v-TAC arterialisation of blood gas values with inclusion 
of 520 patients. A large proportion of patients were detected with abnormal blood gas 
values, but only few showed severely deviating values. However, a majority of these 
patients were at high risk of being overlooked by the physician regarding an assessed 
need for blood gas analysis. In comparing the patients’ blood gas values with their 
assigned level of triage urgency, no obvious associations were detected except for very 
weak correlation between the triage urgency and level of venous lactate.  
In the critically ill patients, the v-TAC method calculated PCO2 values with clinically 
acceptable accuracy. If the v-TAC method were to replace ABG analysis in the 
critically ill patients, higher clinically acceptable thresholds would have to be applied. 
The v-TAC method might not estimate pH values with acceptable validity in critically 
ill patients with diabetic ketoacidosis. This aspect should be assessed in future research.  
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6. PERSPECTIVES 
In patients admitted to the ED and needing assessment of their respiratory or 
metabolic status, the v-TAC method may offer a less painful alternative by venous 
sampling as opposed to arterial puncture. However, if the assessment of oxygenation 
status is imperative, or the patient is critically ill, an ABG sample should always be 
recommended. Also, in clinical situations where only a pH value is necessary to 
determine the severity of acidaemia or alkalemia, a simple VBG sample with slightly 
different normal reference intervals should suffice.  
In the ICU setting, the v-TAC method may not have an obvious role in patients with 
arterial catheters. However, in the assessment of the ventilatory status of patients 
without arterial catheters, the method has potential uses. Likewise, the method may 
also be useful if minor respiratory deterioration is observed in patients during a step-
down discharge process from the ICU.  
The obvious contribution the v-TAC method may deliver is in the patient where 
repeated blood gas is required (e.g., in patients with COPD). These patients in need of 
assessment of ventilatory status may benefit radically from the reduction of painful 
arterial punctures as sample obtainment can be achieved in conjunction with routine 
venous sampling. The v-TAC method seems to provide valid estimates of arterial 
PCO2 values under most conditions and can be used safely.  
We found one patient with severe metabolic acidosis and arterial pH of 7.01 in which 
the v-TAC method wrongfully calculated pH values within normal reference intervals. 
Based on finding in the studies, a further investigation of the validity of the v-TAC 
method in critically ill patients with diabetic ketoacidosis is recommended. 
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Database:  PubMed Medline 
Limits: Species, Humans; Language, English, Danish, Norwegian and 
Swedish; Ages, >12 years; published in the last 10 years. 
Date: March 21, 2019.   
 
Search no. Terms  Results 
#1 "arteries"[MeSH Terms] OR "arterial"[All Fields] OR 
"arterial/venous"[All Fields] OR "arterial/venous 
blood"[All Fields] OR "arterial/venous carbon dioxide 
tension"[All Fields] OR "artery"[All Fields] OR 
oxygenat*[All Fields] OR arteriovenous[All Fields]  
160565 
#2 venous[All Fields] OR "vein"[All Fields] OR 
"venous/arterial"[All Fields] OR "venous/arterial 
blood"[All Fields] OR  "central venous 
catheterization"[MeSH Terms] 
67909 
#3 "analyses, blood gas"[MeSH Terms] OR "analysis, blood 
gas"[MeSH Terms] OR "blood gas analyses"[MeSH 
Terms] OR "blood gas analysis"[MeSH Terms] OR 
"blood gas/acid base"[All Fields] OR "blood gas/acid 
base status"[All Fields] OR "blood gas/oximetry"[All 
Fields] OR "blood gas acid base"[All Fields] OR "blood 
gas status"[All Fields] OR acidosis[All Fields] OR 
alkalosis[All Fields] OR "blood gas analyzer"[All Fields] 
OR "blood gas content"[All Fields] OR "blood gas 
data"[All Fields] OR ph[All Fields] OR co2[All Fields] 
OR o2[All Fields] OR oxygen[MeSH Terms] OR 
"carbon dioxide"[MeSH Terms] OR lactate[All Fields] 
OR bicarbonate[All Fields] OR HCO3*[All Fields] 
1034144 
#4 “comparison, paired”[MeSH Terms] OR “comparisons, 
paired”[MeSH Terms] OR “paired comparison”[MeSH 
Terms] OR “paired comparisons”[MeSH Terms] OR 
agreement[All Fields] OR “bland and altman”[All Fields] 
OR “correlation studies”[MeSH Terms] OR “correlation 
study”[MeSH Terms] OR correlate[Title] OR correlation 
[Title] 
46815 
#5 #1 AND #2 AND #3 AND #4 414 
379 records were excluded on basis of title or abstract.  
35 records were eligible for assessment. 
 
 69 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX 2. ICU DATA CHART 
  
UTILITY OF V-TAC IN THE CLINICAL SETTING 
 70 
 
 
 
 
 
v-TAC på intensiv afdeling 
Ark til dataindsamling 
BEMÆRK: Dette ark skal udfyldes til hvert enkelte prøvesæt  
(et prøvesæt er: ét arterielt udskrift og venøst udskrift fra CVK og/eller PVK). 
Patientlabel:  
 
Dato for prøveindsamling: _________________/_________________ 2018 
Tidspunkt for prøveindsamling:       Kl _____________:______________ 
Ny SAPS 3 score: ________________________________________ 
Indlæggelsesårsag(er):___________________________________________________________ 
   
Vitale parametre: 
 
Saturation:________________________    Respirationsfrekvens:______________________ 
 
Puls: _____________________________    Blodtryk:________________________________ 
 
Temperatur:_______________________ 
 
 
Respiratorindstillinger:  
 
Modus:___________________________     FiO2:________________________________ 
 
Press/PEEP:____________/___________      TV:_________________   
 
 
Cirkulatorisk status:  
 
Perifert varm          Kold distalt for albue                      Kold proksimalt for albue  
 
Cyanose:  
 
Ingen cyanose                             Cyanose lokaliseret til: Negle  Læber    Universel 
 
 
Inotropibehov: 
 
Type:___________________________        Infusionshastighed:__________________________ 
 
Adgange hvorfra blodgas er taget (sæt kryds):  
 
Arteriekateter/-punktur                                          CVK                          PVK  
ID nr._________ 
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Dendrograms from unsupervised machine learning analysis of patients with 
combined caBG and VBG values in the DEPT groups in Study B.  
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Abstract
Arterial blood gas (ABG) analysis is an essential tool in the clinical assessment of acutely ill patients. Venous to arterial 
conversion (v-TAC), a mathematical method, has been developed recently to convert peripheral venous blood gas (VBG) 
values to arterialized VBG (aVBG) values. The aim of this study was to test the validity of aVBG compared to ABG in an 
emergency department (ED) setting. Twenty ED patients were included in this study. ABG and three aVBG samples were 
collected from each patient. The aVBG samples were processed in three different ways to investigate appropriate sample 
handling. All VBG samples were arterialized using the v-TAC method. ABG and aVBG samples were compared using Lin’s 
concordance correlation coefficient (CCC), Bland–Altman plots and misclassification analysis. Clinical acceptable thresh-
old of aVBG value deviance from ABG values were ± 0.05 pH units, ± 0.88 kPa  pCO2 and ± 0.88 kPa  pO2. CCC revealed 
an agreement in pH and  pCO2 parameters for both aVBG in comparison to ABG. In all aVBG samples, an overestimation 
of  pO2 compared to ABG was observed. Bland–Altman plot revealed clinically acceptable mean difference and limits-of-
agreement intervals between ABG and aVBG pH and  pCO2, but not between ABG and aVBG  pO2. Arterialization of VBG 
using v-TAC is a valid method for measuring pH and  pCO2, but not for  pO2. Larger clinical studies are required to evaluate 
the applicability of v-TAC in different patient subpopulations.
Keywords Arterial blood gas analysis · Emergency service, hospital · Venous to arterial conversion · Matched-pair analysis
1 Introduction
Arterial blood gas (ABG) analysis is essential in assessment 
of respiratory and metabolic status in acutely ill patients. In 
comparison to peripheral venous blood sampling, the ABG 
sampling procedure is more painful for the patient and tech-
nically more challenging for the clinician to perform [1, 2]. 
Other drawbacks of ABG sampling include adverse events 
such as subcutaneous hematoma, arterial thrombosis, and 
the serious, though rare, complication pseudoaneurysms [3, 
4].
Peripheral venous blood gas (VBG) sampling has been 
suggested as an alternative to the ABG procedure. This pro-
cedure causes less patient discomfort and the sample can 
be analysed in combination with other venous blood tests 
[5]. A recent systematic review comparing ABG and VBG 
in the emergency department (ED) have revealed that pH 
and bicarbonate show reasonable agreement with mean 
difference − 0.033 pH units and 1.03 mmol/l bicarbonate, 
respectively. Limits-of-agreement was − 0.13 to 0.10 for pH 
and − 6.24 mmol/l to 10.00 mmol/l for bicarbonate.  pCO2 
showed mean difference of 4.41 mmHg and wide limits-of-
agreement of − 20.40 to 25.8 mmHg. Authors concluded that 
 * Mads Lumholdt 
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venous and arterial pH and bicarbonate agree acceptable, but 
arteriovenous agreement of  pCO2 was poor [6].
However, a new method has been developed to calculate 
ABG values mathematically from peripheral venous blood 
by use of venous to arterial conversion (v-TAC) software 
(Obimedical, Denmark), supplemented with oxygen satura-
tion measurement by pulse oximetry [7]. The principle of 
the method is a mathematical transformation of VBG values 
to arterialized values (aVBG) by simulating the transport of 
blood back through the tissue. The authors made assump-
tions; Firstly, the peripheral limb must be well perfused with 
normal capillary response and temperature. Secondly, the 
respiratory quotient [RQ, i.e. rate of  CO2 production  (VCO2) 
and  O2 utilisation  (VO2)] must not vary beyond the range 
of 0.7–1.0.
Earlier testing of the v-TAC method in an ED setting has 
shown acceptable congruence levels between arterial and 
mathematically arterialized pH and  pCO2 with only minor 
differences (± 2 × SD) − 0.001 (± 0.024) and 0.00 (± 0.46) 
kPa, respectively. However, inaccurate values of  pO2 were 
observed when oxygen saturation measured by pulse oxi-
metry was above 96%, due to the flat shape of the oxygen 
dissociation curve (ODC) at higher oxygen saturation [8].
The aim of this study was to evaluate the validity of the 
v-TAC method in an acute medical emergency setting and 
test appropriate practical handling of VBG samples.
2  Methods
2.1  Patient inclusion
The study was conducted in the ED at the North Denmark 
Regional Hospital from September through October 2015. 
Circulatory stable patients needing ABG analysis for clini-
cal respiratory and metabolic assessment were selected 
randomly for participation in the study. A total of 30 adult 
patients were included; 10 patients for a methodological pre-
study and then 20 patients for the following validation study 
and test of different blood samples procedures. Allocation 
was performed by simple quasi-random algorithm in order 
of admission. The clinical decision for performance of ABG 
analysis was made on discretion by the attending physician 
in the ED upon patient admission and based on national 
guidelines [9].
2.2  Blood collection
All VBG samples were collected by a biomedical laboratory 
technician in conjunction with routine venous blood sam-
pling in the methodological pre-study. VBG was collected 
in the 4.5 ml tube as opposed to the arterial blood 2.0 ml 
syringe as a three-way stopcock would have to be coupled 
with the venous blood sampling kits, but we found this 
inconvenient in our hospital setting. Furthermore, biomedi-
cal laboratory technicians were at risk of accidental needle 
injury if a syringe was coupled directly over the sampling 
kit needle. For that reason, we conducted this methodologi-
cal pre-study to compare VBG samples in paired 2.0 ml and 
ABG syringes.
2.3  Blood sample handling
In the validation study paired ABG and VBG samples were 
collected simultaneously from each of the 20 patients. Blood 
for VBG analysis was collected by the laboratory techni-
cian in three 4.5 ml tubes and converted to arterialised VBG 
(referred to as aVBG). ABG samples were collected by the 
attending physician. Each aVBG tube was processed differ-
ently as follows:  aVBG1 was held steady and analysed within 
5 min of sample collection,  aVBG2 was tilted in 5 min and 
analysed after 7 min and  aVBG3 was handled as  aVBG1 but 
analysed after 15 min. ABG samples were analysed within 
5 min after sampling.
2.4  Blood analysis
All ABG and VBG samples were analysed with ABL800 
blood gas analyser (Radiometer, Denmark) an VBG sam-
ples were converted mathematically to aVBG using v-TAC 
software integrated into the ABL800. Figure 1 show calcu-
lations of the v-TAC simulation in five steps (A–E) [7]. On 
the standard of care basis, only the ABG results were used 
as the usual standard reference in the medical evaluation 
of the patients. Normal reference ranges of study variables 
were as follows pH, 7.35–7.45,  pCO2, 4.26–6.38 kPa and 
 pO2, 10.6–13.3 kPa, respectively [10].
2.5  Threshold values
In this present study, clinically acceptable thresholds 
between ABG and aVBG values were determined as ± 0.05 
for pH, and ± 0.88 kPa for both  pCO2 and  pO2. Conse-
quently, clinically acceptable intervals of calculated arterial 
values were determined to be 0.1 pH units and 1.76 kPa for 
both  pCO2 and  pO2 compared to ABG values. Acceptable 
rate of misclassification was set to 5% as in a similar study 
[11]. Extreme-to-extreme misclassification was not allowed.
2.6  Sample size
A previous study on the v-TAC method reported mean dif-
ference (± 2 × SD) of − 0.001± 0.024 and − 0.00 ± 0.46 kPa 
between calculated arterial and ABG pH and  pCO2, respec-
tively [8]. With the predetermined clinical acceptable thresh-
old of calculated arterial pH ± 0.05 and  pCO2 ± 0.88 kPa, 
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the requires study sample size (alpha level 0.005 and 80% 
power) was estimated to 11 paired samples with pH as refer-
ence and 14 paired samples with  pCO2 as reference using 
MedCalc v18.6 (MedCalc Software bvba) sample size calcu-
lator for agreement studies. If power was increased to 90%, 
13 and 16 paired samples, respectively, were sufficient using 
pH and  pCO2 as reference. Because, SD of  pO2 was missing 
in the study [8], a sufficient sample size could, therefore, not 
be calculated with  pO2 as reference.
2.7  Statistics
Assessment of agreement between sample collection 
methods, and between ABG and aVBG values, were con-
ducted using Bland–Altman’s analysis, Pearson’s correla-
tion coefficient (PCC), and Lin’s concordance correlation 
coefficient (CCC). Strength of agreement was assessed by 
calculating tolerability interval ratio, which is the actual 
limits-of-agreement interval in this study expressed as 
the proportion of the clinically acceptable interval [12]. 
Additionally, rate of misclassification and rate of extreme-
to-extreme misclassification is calculated for individual 
sample pairs with ABG values as gold standard [12]. Sta-
tistical analysis was conducted using Stata 13 SE (Stata-
Corp, College Station).
2.8  Ethics and data protection
This study was approved by the Danish Data Protection 
Agency. The Danish Research Ethics Committee in the 
North Denmark Region was notified about the study. Since 
the v-TAC method has previously been approved in clini-
cal research and blood sampling was performed as routine 
practice based on clinical indication, ethical approval was 
not required.
Fig. 1  Calculation of arterial acid–base and oxygen values from VBG 
using v-TAC. Step A an anaerobic venous blood sample is collected 
and  pHv,  pCO2,v,  SO2,v,  pO2,v, haemoglobin  (Hbv), methaemoglobin 
 (MetHbv), and carboxyhaemoglobin  (COHbv) are measured. Step 
B measured values are used to calculate total  CO2 concentration 
 (tCO2,v), total  O2 concentration  (tO2,v) and 2,3-diphosphoglycer-
ate concentration  (DPGv) in venous blood. Base excess is estimated 
independently of  O2 levels by calculating the total concentration of 
plasma non-bicarbonate buffer  (tNBBp,v) and combining the concen-
tration with  pHv. Step C variables  tCO2,v,  tO2,v,  Hbv,  BEv,  DPGv and 
 tNBBp,v are used to estimate the respective variables in arterial blood. 
It is assumed that Hb,  tNBBp and DPG concentrations are the same 
in arterial and venous blood. Calculations of arterial  O2 and  CO2 is 
then performed by simulating addition of a difference in  O2 concen-
tration (ΔO2), to the venous  pO2 measurement and removing a differ-
ence in concentration of  CO2 (ΔCO2) from  pCO2 in the venous blood. 
Step D calculated values of arterialised blood  tCO2,a,  tO2,a,  Hbv,  BEa, 
 tNBBp,a and  DPGa are used to estimate  pHa,  pCO2,a,  pO2,a and  SO2,a. 
Step E calculated  SO2,a is compared with measured pulse oximeter 
 (SpO2), the difference between the two gives an error = SO2,a–SpO2. 
By repeating steps C–E, a value of ΔO2 is found for which the error is 
zero. Multiplying the respiratory quotient (RQ) with ΔO2, the concen-
tration of  CO2 removed is calculated. Thus calculated values of  pHa, 
 pCO2,a,  pO2,a and  SO2,a should be equal to measured arterial values. 
Reproduced with permission from publisher [7]
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3  Results
3.1  Methodological pre-study
Median age of the ten patients in the methodological pre-
study was 56 years (range 26–86). Comparison of paired 
VBG samples collected in 2 ml syringes and 4.5 ml tubes 
displayed close correlation with mean difference (SD) of pH 
and  pCO2 was on 0.01 (0.01) pH units and − 0.02 (0.27) kPa, 
respectively, and CCC values was 0.925 and 0.943 (Table 1). 
However,  pO2 displayed poor agreement between the two 
sampling containers with a mean difference (SD)  pO2 value 
of − 0.57 (1.10) kPa and CCC value on 0.660 because mean 
 pO2 (SD) was higher in the tube, 4.74 (1.66) kPa, compared 
to the syringe, 4.18 (1.22) kPa.
3.2  The validation study
Median age of the 20 patients was 66  years (range 
36–96 years). All patients were circulatory stable and none 
suffered from severe respiratory failure. Patient characteris-
tics are presented in Table 2. Comparison analysis between 
ABG and aVBG samples are summarised in Table 3. The 
CCC displayed good agreement between pH and  pCO2 in all 
comparison of ABG and aVBG, except between ABG and 
 aVBG2  pCO2, where a CCC value of 0.639 displayed weak 
agreement. Overestimation of  pO2 in aVBG samples resulted 
in a higher mean difference (SD) − 0.97 (1.32) kPa, − 1.25 
(1.73) kPa and − 1.00 (1.34) kPa in the three aVBG samples 
compared to ABG. Therefore, CCC analysis displayed poor 
agreement values of 0.720, 0.652 and 0.716 between ABG 
and  aVBG1+2+3  pO2.
3.3  Bland and Altman analysis
Bland and Altman plots are presented in Fig.  2. The 
Bland–Altman findings were in accordance with the 
CCC findings in the validation study. Mean pH difference 
between ABG and  aVBG1 and between ABG and  aVBG3 
was within predefined threshold values. Mean difference 
between all  aVBG2 pH samples and ABG pH samples was 
within acceptable threshold range. Similar tendencies were 
observed when comparing  pCO2 results. Mean difference 
in  pCO2 was within predefined acceptable threshold range 
in overall comparison between all ABG and aVBG  pCO2 
values (Table 2), but at an individual patient level, three 
 aVBG2  pCO2 samples were above threshold values, hence 
rate of misclassification was 15%. Mean difference of  pO2 
between ABG and all aVBG samples was unacceptably 
above predefined thresholds regardless of sample handling 
procedure. This was caused by overestimation of  pO2 in a 
Table 1  Comparison of blood 
gas sampling in 2 ml ABG 
syringe and 4.5 ml tube in the 
pre-study patients (n = 10)
Comparison of sample containers in group A: CCC Lin’s concordance correlation coefficient, 95% CI 95% 
confidence interval of CCC, r Pearson’s correlation coefficient, Cb bias-correction factor, kPa kilopascal
Parameters ABG syringe
Mean (SD)
Tube
Mean (SD)
Mean difference
(SD)
Concordance correlation analysis
CCC 95% CI r Cb
pH 7.39 (0.04) 7.39 (0.03) 0.01 (0.01) 0.925 0.838–1.013 0.949 0.975
pCO2 (kPa) 5.90 (0.82) 5.91 (0.75) − 0.02 (0.27) 0.943 0.869–1.017 0.947 0.996
pO2 (kPa) 4.18 (1.22) 4.74 (1.66) − 0.57 (1.10) 0.660 0.326–0.994 0.750 0.880
Table 2  Characteristics of patients in the validation study
Patient characteristics and comorbidities in the validation study
COPD chronic obstructive pulmonary disease, IHD ischemic heart 
disease
Patient parameters n (%)
Age (year)
 ≤ 64 5 (25)
 65–74 6 (30)
 ≥ 75 9 (45)
Sex
 Female 8 (40)
 Male 12 (60)
Cause of admission
 COPD exacerbation 6 (30)
 Pneumonia 3 (15)
 Suspected abdominal ischemia 3 (15)
 Dehydration 3 (15)
 Cor pulmonale 2 (10)
 Diabetic ketoacidosis 1 (5)
 Dysregulated diabetes mellitus 1 (5)
 Bleeding haemorrhoid 1 (5)
Comorbidities
 COPD 8 (40)
 Heart failure 5 (25)
 Essential hypertension 4 (20)
 IHD 2 (10)
 Arterial fibrillation 2 (10)
 Diabetes mellitus 2 (10)
 Myxoedema 1 (5)
 Small cell carcinoma 1 (5)
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majority of the  aVBG1 (n = 12),  aVBG2 (n = 12) and  aVBG3 
(n = 11) samples.
3.4  Tolerability interval ratio
The strength of limits-of-agreement expressed as the toler-
ability interval ratio was 0.65, 0.77 and 0.64, respectively, in 
pH between ABG and all three  aVBG1+2+3 samples. Being 
less than one in each single comparison, it can be concluded 
that the limits-of-agreement interval is sufficiently narrow 
for pH as to assure correct assessment of patients’ blood 
gas values when using v-TAC. Likewise, tolerability interval 
ratio in  pCO2 between ABG and all three  aVBG1+2+3 sam-
ples was 0.48, 0.63 and 0.53. However, tolerability interval 
ratios for  pO2 agreement was 2.94, 3.84 and 2.97 between 
ABG and  aVBG1, ABG and  aVBG2 and ABG and  aVBG3, 
respectively, which is above two and therefore unacceptable.
3.5  Misclassification
Rate of misclassification was zero comparing pH in the 
 aVBG1 and ABG, and  aVBG3 and ABG sample pairs. The 
 aVBG2 versus ABG pH rate of misclassification was 10% 
(2/20). Similar tendencies were observed comparing  pCO2, 
with  aVBG1 versus ABG, and  aVBG3 versus ABG rate of 
misclassification of zero, but 15% (3/20) in  aVBG2 versus 
ABG  pCO2. Rate of misclassification was 60% (12/20), 60% 
(12/20) and 55% (11/20) between ABG versus  aVBG1+2+3 
 pO2, respectively.
No extreme-to-extreme misclassification occurred com-
paring aVBG versus ABG in pH and  pCO2. Extreme-to-
extreme misclassification was 25% (5/20), 25% (5/20) and 
25% (5/20) between ABG and  aVBG1+2+3  pO2 values, 
respectively.
4  Discussion
This study has shown that the v-TAC method delivers clini-
cally valid information on pH and  pCO2 in patients admitted 
to the ED. Bland and Altman differences were within prede-
fined clinical acceptable threshold ranges for pH and  pCO2 
between ABG and aVBG sample pairs. Analogously, toler-
ability interval ratios were below one between all ABG and 
aVBG comparison in the parameters pH and  pCO2, hence it 
can be concluded that the limits-of-agreement interval was 
sufficiently narrow for the two parameters in all aVBG and 
ABG sample pairs as to assure correct assessment and treat-
ment of patients when using v-TAC in daily clinical practice. 
Difference between ABG and calculated aVBG  pO2, how-
ever, was outside predefined threshold ranges in all sampled 
pairs. Moreover, tolerability interval ratio showed unac-
ceptable broad limits-of-agreement and a rate of extreme-
to-extreme misclassifications as high as 25%. Reliable 
acid–base and blood gas values are important for correct 
patient treatment in the ED setting, thus extreme-to-extreme 
misclassification was not allowed. Extreme-to-extreme mis-
classification could result in undertreatment of patients with 
severely abnormal acid–base or blood gas values.
As also observed in this study, research team behind the 
v-TAC method found high levels of  pO2 in aVBG samples 
compared to ABG, but argued that the poor agreement is 
due to the flat shape of the ODC close to 100% blood oxy-
gen saturation level [7]. Even minor changes in blood  O2 
Table 3  Comparison of ABG 
and arterialized VBG values 
in the validation study patients 
(n  = 20)
Comparison analysis of ABG and aVBG in group B
ABG arterial blood gas, aVBG arterialised venous blood gas, CCC Lin’s concordance correlation coeffi-
cient, 95% CI 95% confidence interval of CCC, r Pearson’s correlation coefficient, Cb  bias-correction fac-
tor, kPa kilopascal
a aVBG analysed within 5 min after sampling
b aVBG tilted in 5 min and analysed after 7 min
c aVBG held steady and analysed after 15 min
Parameters ABG
Mean (SD)
aVBG
Mean (SD)
Mean difference (SD) Concordance correlation analysis
CCC 95% CI r Cb
pH 7.42 (0.05) 7.42 (0.05)a 0.00 (0.02)a 0.939a 0.885–0.994a 0.941a 0.998a
7.39 (0.04)b 0.03 (0.02)b 0.744b 0.590–0.899b 0.918b 0.811b
7.42 (0.05)c 0.00 (0.02)c 0.942c 0.891–0.994c 0.942c 1.000c
pCO2 (kPa) 4.94 (0.62) 4.98 (0.61)a − 0.05 (0.22)a 0.935a 0.878–0.993a 0.938a 0.997a
5.48 (0.61)b − 0.54 (0.28)b 0.639b 0.453–0.825b 0.895b 0.714b
4.95 (0.60)c − 0.01 (0.24)c 0.923c 0.856–0.991c 0.924c 0.999c
pO2 (kPa) 10.28 (1.76) 11.24 (2.38)a − 0.97 (1.32)a 0.720a 0.539–0.902a 0.837a 0.861a
11.53 (2.92)b − 1.25 (1.73)b 0.652b 0.467–0.838b 0.841b 0.775b
11.27 (2.41)c − 1.00 (1.34)c 0.716c 0.534–0.898c 0.839c 0.854c
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saturation may affect calculated  pO2 pressure significantly 
when saturation is above 96%. At low  O2 saturation calcu-
lating  pO2 should be more accurate due to the steepness of 
the ODC at  O2 saturation. The same principle applies to 
the ABG analysis regarding the difference between ABG 
and aVBG  pO2 values [13]. The selected sample collection 
tube in the study may also explain the overestimated  pO2 
values. In the methodological pre-study mean venous  pO2 
was 0.57 kPa higher in the 4.5 ml tube compared with the 
syringe. Furthermore, the correlation between containers 
was poor. Higher oxygen values could have been caused by 
oxygen bubbles in the venous blood sampling kit, which 
have been sucked into the tube and then absorbed by the 
venous blood. Leftover oxygen in the vacuum of the tubes 
could also explain this difference. Hence, the observed 
overestimation of calculated aVBG  pO2 in the valida-
tion study could very well be related to an inappropriate 
choice of sample container, and the reliability of v-TAC 
 pO2 should be investigated further in different sample con-
tainers, before its use is ruled out in the ED setting.
It was surprising that the v-TAC method managed to 
calculate  pCO2 with both accuracy and precision, as estab-
lished previously, the method relies on calculated arterio-
venous difference in  O2 to calculate  pCO2 values (step E 
in Fig. 1). Since calculated  pO2 is generally overestimated 
and limits-of-agreement was observed at an unacceptable 
level in this study, the accuracy of the difference in  O2 
may not be of major importance in the overall calculation.
Tilting of  VBG2 samples collected in 4.5  ml tubes 
caused an increase of  pCO2 and lowered pH, which 
resulted in misclassification rate of  aVBG2  pCO2 just 
above the predefined 5% threshold. Although a larger 
sample size might lower the misclassification rate for cal-
culated  pCO2, careful sample handling should be advised 
to obtain valid estimations of  pCO2.
Fig. 2  Bland and Altman plots of ABG and aVBG value agreement 
in the validation study. a ABG and  aVBG1; b ABG and  aVBG2; c 
ABG and  aVBG3. ABG arterial blood gas, aVBG arterialized venous 
blood gas, CCC Lin’s concordance correlation coefficient, 95% CI 
95% confidence interval of CCC, r Pearson’s correlation coefficient, 
Cb  bias-correction factor. aVBG1 analysed within 5  min after sam-
pling. aVBG2 tilted in 5 min and analysed after 7 min. aVBG3 held 
steady and analysed after 15 min
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McCanny et al. reject VBG as a reliable alternative to 
ABG due to variations in venous  pCO2 agreement with 
arterial  pCO2 [14]. Bland and Altman’s plot demonstrated 
average difference in 8.6 mmHg (1.15 kPa) and limits of 
agreement from − 7.84 mmHg (− 1.02 kPa) to 25.05 mmHg 
(3.34 kPa) between venous and arterial  pCO2 [14]. Although 
only 20 patients were included in the present study clini-
cally acceptable difference and narrow limits-of-agreement 
of  pCO2 between aVBG and ABG were observed. Therefore, 
the v-TAC could contribute to make for a more precise esti-
mation of arterial  pCO2.
Clinically acceptable ranges of difference between ABG 
and aVBG is challenging to determining. Either, normal 
reference ranges are used as tolerable intervals [12], or 
alternatively acceptable laboratory intervals are calculated 
(± 2 × SD) [15]. In questionnaire-based survey certified 
ED physicians reported maximum figures they would feel 
comfortable about regarding differences between monitored 
arterial and calculated arterial values for pH and  pCO2 in 
clinical practice. The results were as follows: mean (95% CI) 
0.05 (0.04–0.06) for pH and 0.88 (0.74–1.01) kPa for  pCO2 
[16]. These acceptable thresholds were used in this present 
study. Values for  pO2 were not covered in the survey.
According to the research team behind the v-TAC 
method, the peripheral limp has to be well perfused and the 
respiratory quotient has to be within 0.7 and 1.0 for v-TAC 
to deliver accurate estimates of ABG [7]. In this present 
study all included patients were circulatory stable and no 
one suffered from severe respiratory failure. However, in 
the critically ill patient, both the respiratory quotient and 
peripheral blood perfusion may vary considerably, depend-
ing on the underlying pathophysiological mechanisms [17, 
18]. The v-TAC method may not be appropriate to assess 
patients with extreme conditions, but it may be able to iden-
tify potential critically ill patients with extreme acid–base 
status or blood gas values in a mixed ED patient population.
Our study has a number of limitations. It was designed 
as a single-centre study with a small number of participants 
without specific clinical characteristics. Hence, in this het-
erogenous study group results could not be generalised. 
Moreover, randomisation was performed by a simple quasi-
random allocation and the study results suggest that anaero-
bic sampling might not have been guaranteed in the 4.5 ml 
tube even if air bubbles in the venous blood sampling kit 
was avoided.
In medical departments where repeated blood gas is 
required (e.g. in patients with COPD), the v-TAC method 
may reduce the need for repeated painful arterial punctures, 
since sampling of blood gas is achieved in conjunction with 
routine venous blood sampling. The reliability and utility 
of method should be examined in large studies, preferably 
multicentre studies, which renders subdivision of patients 
into groups according to cause of admission, severity of 
symptoms or conditions (e.g. hypoxia, hypo- or hypercapnia, 
severe acidosis or severe anaemia) in order to clarify under 
which conditions this method is reliable.
5  Conclusion
Mathematical arterialisation of VBG was found to be a valid 
method for calculation of pH and  pCO2 ABG values in cir-
culatory stable ED patients, whereas the arterialised values 
of  pO2 showed overestimation and clinically unacceptable 
broad limits-of-agreement. This observation could be due 
to the venous blood sampling procedure in which 4.5 ml 
tubes were used. The usability of v-TAC in critically ill 
patients with reduced peripheral blood perfusion or extreme 
acid–base or blood gas values remains to be explored in 
future studies.
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